Medical diagnosis Books

Book SynopsisTable of ContentsCHAPTER 1 Basics of Conversational Spanish 1.1 Pronunciation 1.2 Syntax and Grammar 1.3 Verb Conjugation 1.4 Addressing the Patient: Tú versus Usted CHAPTER 2 Setting the Stage for the Clinical Encounter 2.1 General Greetings 2.2 Addressing the Patient 2.3 Provider's Introduction 2.4 Extended Introduction: Getting to Know the Patient 2.5 Setting the Agenda CHAPTER 3 History of the Present Illness 3.1 Basic Anatomy 3.2 Chief Complaint 3.3 History of the Present Illness CHAPTER 4 Past Medical History and Review of Systems 4.1 Past Medical History of Chronic Diseases 4.2 Past Medical History of Acute Diseases 4.3 Past Surgical History 4.4 Review of Systems CHAPTER 5 Medications and Drug Effects 5.1 Medication History 5.2 Allergy History 5.3 Medication Instructions 5.4 Drug Side Effects 5.5 Diabetes Medication CHAPTER 6 Family History 6.1 Naming Family Members 6.2 Talking about Family Life and Health 6.3 Family History CHAPTER 7 Social and Sexual History 7.1 Assuring the Patient of Confidentiality 7.2 Social History 7.3 Travel History and Special Exposures 7.4 Substance Use History 7.5 Sexual History 7.6 Review of Reproductive Systems CHAPTER 8 Mental Health and Cognition 8.1 General Mental Health 8.2 Spirituality and Health 8.3 Cognitive Assessment 8.4 Psychiatric History and Review of Systems CHAPTER 9 Preventive Health and Nutrition 9.1 Access to Preventive Medical Care 9.2 Preventive Routine Screening Tests 9.3 Adult Immunization History 9.4 Exercise and Adult Health Safety Screening 9.5 Diet History 9.6 Body Mass Index, Special Diets, and Recommendations CHAPTER 10 Pediatrics 10.1 Addressing the Pediatric Patient 10.2 Pregnancy, Delivery, and Neonatal History 10.3 Developmental History 10.4 Pediatric Safety 10.5 Immunization History 10.6 Infant Diet 10.7 Common Pediatric Illnesses CHAPTER 11 Physical Examination 11.1 General Physical Examination 11.2 Specialized Physical Examination 11.3 Physical Findings CHAPTER 12 Procedures and Informed Consent 12.1 Informed Consent 12.2 Discussing Common Procedures 12.3 Discussing Emergent Procedures 12.4 Advanced Directives CHAPTER 13 Impression and Plan 13.1 Physician's Impression 13.2 Plan of Care: Additional Testing 13.3 Plan of Care: Treatment and Follow-up 13.4 Discussing Test Results 13.5 Delivering Bad News 13.6 System-Based Summary of Impression and Plan 13.7 Concluding the Visit CHAPTER 14 Knowing your Limitations: When and How to Use a Medical Interpreter 14.1 When to Use a Medical Interpreter 14.2 Types of Medical Interpretation 14.3 Working Effectively with a Medical Interpreter APPENDIX Abbreviated Spanish Medical Interview Guide Extended Spanish Medical Interview Guide ANSWER KEY BIBLIOGRAPHY INDEX

Read more less

Book SynopsisTrade Review"This is an excellent resource for any pathologist who wants to brush up on infectious histopathology or to have scope-side for expert consultation. Microbiologists will love the clinical correlate to the microorganisms with which they're so familiar. Users of the first edition will be pleased with the update and pathologists looking for a new reference for infectious histopathology can stop here!" Reviewed by Sarah L. Rooney, BA, MD (University of Michigan Medical School) Doody's Score: 96, 4 Stars!Table of Contents1. Introduction 2. General Principles in the Diagnosis of Infection 3. Biopsy in the Diagnosis of Infection: Clinical Approach 4. Cytopathology of Infectious and Inflammatory Diseases 5. Ultrastructural Diagnosis of Infection 6. New Techniques for the Diagnosis of Infection 7. Ear, Nose, and Throat Infections 8. Pathology of Pulmonary Infection 9. Cardiac Infections 10. Infections of the Gastrointestinal Tract 11. Liver and Bile Duct Infections 12. Infectious Lymphadenitis 13. Infectious Diseases of the Bone Marrow and Spleen 14. Infection of Bone 15. Infections of Joints, Synovium-lined Structures, and Soft Tissue 16. Genitourinary Infectious Disease Pathology 17. Gynecological Infections 18. Perinatal Infections 19. Infections of the Nervous System 20. Skin Infections 21. Infections of the Eye and Its Adnex

Read more less

Book SynopsisTrade Review"This thoracic pathology book provides an excellent and concise description of key features for each entity with excellent corresponding images. Both neoplastic and non-neoplastic entities are covered with the same degree of detail. This book will be a useful resource for those in training (residents and fellows alike) as well as practicing pathologists, both academic and private." ©Doody's Review Service, 2022, Maxwell Dong Wang, MD (University of Michigan Medical School) Doody's Score: 4 Stars!Table of ContentsSECTION 1: LUNG NEOPLASMS, BENIGN 4 Congenital Peribronchial Myofibroblastic Tumor David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 6 Fetal Lung Interstitial Tumor David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 8 Mucous Gland Adenoma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 12 Ciliated Muconodular Papillary Tumor David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 14 Alveolar Adenoma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 18 Sclerosing Pneumocytoma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 24 Cartilaginous Hamartoma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 28 Endobronchial Lipoma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 30 Pulmonary Adenofibroma/Adenomyoma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 34 Glomus Tumor David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 36 Pulmonary Paraganglioma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 40 Pulmonary Meningioma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 44 Minute Pulmonary Meningothelial-Like Nodule David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 48 Granular Cell Tumor David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 50 Langerhans Cell Histiocytosis David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 54 Erdheim-Chester Disease David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 58 Clear Cell Sugar Tumor (PEComa) David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 62 Lymphangioleiomyomatosis David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD NEOPLASMS, MALIGNANT, PRIMARY ADENOCARCINOMA 66 Overview of Malignant Epithelial Neoplasms of Lung David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 70 Conventional Adenocarcinoma Mari Mino-Kenudson, MD, David I. Suster, MD, and Saul Suster, MD 82 Lepidic Predominant Adenocarcinoma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 84 Invasive Mucinous Adenocarcinoma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 88 Colloid Adenocarcinoma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 92 Fetal Adenocarcinoma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 96 Enteric-Type Adenocarcinoma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 98 Other Adenocarcinoma Variants David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 102 Adenosquamous Carcinoma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD SQUAMOUS CELL CARCINOMA 106 Conventional Squamous Cell Carcinoma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 112 Basaloid/Small Cell Variant of Squamous Cell Carcinoma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 116 Lymphoepithelioma-Like Carcinoma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD NEUROENDOCRINE CARCINOMA AND PRECURSOR LESIONS 120 Overview of Neuroendocrine Neoplasms David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 124 Pulmonary Tumorlet and Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 126 Low-Grade Neuroendocrine Carcinoma (Typical Carcinoid Tumor) David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 132 Intermediate-Grade Neuroendocrine Carcinoma (Atypical Carcinoid Tumor) David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 136 High-Grade Neuroendocrine Carcinoma, Small Cell Type David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 140 High-Grade Neuroendocrine Carcinoma, Large Cell Type David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD POORLY DIFFERENTIATED NON-SMALL CELL CARCINOMAS 144 Overview of Poorly Differentiated Non-Small Cell Carcinomas David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 146 Large Cell Carcinoma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 148 Pleomorphic Carcinoma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 152 Spindle Cell Carcinoma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 156 Carcinosarcoma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 160 Pulmonary Blastoma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 164 SMARCA4-Deficient Undifferentiated Tumors David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 168 NUT Carcinoma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD SALIVARY GLAND-TYPE TUMORS 170 Adenoid Cystic Carcinoma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 176 Mucoepidermoid Carcinoma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 182 Epithelial-Myoepithelial Carcinoma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 186 Acinic Cell Carcinoma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 190 Mixed Tumor (Pleomorphic Adenoma) David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 194 Myoepithelial Carcinoma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD MESENCHYMAL NEOPLASMS 198 Pleuropulmonary Blastoma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 202 Primary Pulmonary Myxoid Sarcoma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 204 Intrapulmonary Solitary Fibrous Tumor David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 208 Leiomyosarcoma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 212 Intrapulmonary Synovial Sarcoma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 218 Malignant Peripheral Nerve Sheath Tumor David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 222 Osteosarcoma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 226 Chondrosarcoma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 230 Epithelioid Hemangioendothelioma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 238 Angiosarcoma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 242 Kaposi Sarcoma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 246 Intimal Sarcoma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD Suster, MD 266 Hodgkin Lymphoma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 270 Plasmacytoma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 272 Lymphomatoid Granulomatosis David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD OTHER RARE TUMORS AND BENIGN PSEUDOTUMORAL CONDITIONS 278 Inflammatory Myofibroblastic Tumor David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 282 Intrapulmonary Thymoma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 286 Ganglioneuroblastoma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 290 Primary Pulmonary Melanoma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 294 Juvenile Xanthogranuloma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 298 Hyalinizing Granuloma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 302 Metastatic/Dendriform Calcification David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 306 Lipoid Pneumonia (Paraffinoma) David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 308 Placental Transmogrification David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 312 Rosai-Dorfman Disease David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 316 Epithelioid Hemangioma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD NEOPLASMS, METASTATIC 318 Benign Metastasizing Leiomyoma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 322 Metastatic Carcinoma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 334 Metastatic Sarcoma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 344 Metastatic Malignant Melanoma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD NONNEOPLASTIC AND SYSTEMIC CONDITIONS 352 Diffuse Alveolar Damage David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 356 Acute Fibrinous and Organizing Pneumonia David I. Suster, MD 358 Organizing Pneumonia David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 362 Eosinophilic Pneumonia David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 366 Respiratory Bronchiolitis Interstitial Lung Disease David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 368 Other Smoking-Related Changes David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 370 Desquamative Interstitial Pneumonia David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 374 Usual Interstitial Pneumonia David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 380 Nonspecific Interstitial Pneumonia David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 384 Granulomatous-Lymphocytic Interstitial Lung Disease David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 388 Pleuroparenchymal Fibroelastosis David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 390 Hypersensitivity Pneumonitis David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 394 Bronchocentric Granulomatosis David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 396 Sarcoidosis David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 400 IgG4 Sclerosing Lung Disease David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 404 Pulmonary Amyloidosis David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 408 Light Chain Deposition Disease (Pseudoamyloid) Saul Suster, MD 412 Diffuse Alveolar Hemorrhage With and Without Capillaritis David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 414 Granulomatosis With Polyangiitis (Wegener Granulomatosis) David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 418 Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss) David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 422 Microscopic Polyangitis David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 424 Pulmonary Veno-Occlusive Disease / Pulmonary Capillary Hemangiomatosis David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 428 Idiopathic Pulmonary Hemosiderosis David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 430 Hard Metal Pneumoconiosis David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 432 Asbestos-Related Interstitial Fibrosis/Asbestosis David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 436 E-Cigarette and Vaping-Associated Lung Injury David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 438 Alveolar Proteinosis David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 442 Alveolar Microlithiasis David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 446 Congenital Pulmonary Airway Malformations David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD PARASITIC DISORDERS 450 Strongyloidiasis David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 454 Dirofilariasis David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 458 Schistosomiasis David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 460 Echinococcosis (Hydatid Cyst) David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 462 Paragonimiasis David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD INFECTIOUS DISEASES 464 Cryptococcosis David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 468 Coccidioidomycosis David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 472 Pneumocystosis David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 476 Blastomycosis David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 478 Histoplasmosis David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 482 Tuberculosis David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 486 Herpes Simplex Virus David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 490 Cytomegalovirus David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 492 Adenovirus David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 494 Measles Pneumonia David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 498 Sporotrichosis David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 500 Klebsiella Pneumonia David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 504 Legionnaires' Disease David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 506 SARS Pneumonia David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 512 Nocardiosis David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 514 Actinomycosis David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 516 Aspergillosis David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 522 Mucormycosis (Zygomycosis) David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 524 Botryomycosis David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 526 Malakoplakia David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD SECTION 2: PLEURA NEOPLASMS, BENIGN 532 Mesothelial Hyperplasia David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 534 Solitary Fibrous Tumor David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 542 Calcified Fibrous Pseudotumor David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD NEOPLASMS, MALIGNANT, PRIMARY MESOTHELIAL NEOPLASMS 546 Malignant Mesothelioma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 558 Well-Differentiated Papillary Mesothelioma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD OTHER MALIGNANT NEOPLASMS 562 Mucoepidermoid Carcinoma of Pleura David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 566 Angiosarcoma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 572 Synovial Sarcoma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 578 Smooth Muscle Tumors of Pleura David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 582 Desmoplastic Small Round Cell Tumor David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 586 Primary Effusion Lymphoma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD EPITHELIAL NEOPLASMS 588 Overview of Malignant Pleural Neoplasms David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD OTHER LESIONS OF PLEURA 590 Pleuropulmonary Endometriosis David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD SECTION 3: MEDIASTINUM NEOPLASMS, BENIGN 596 Lymphangioma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 600 Hemangioma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 604 Paraganglioma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 608 Schwannoma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 612 Neurofibroma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD NEOPLASMS, MALIGNANT, PRIMARY EPITHELIAL NEOPLASMS 616 Overview of Malignant Thymic Neoplasms David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 618 Thymoma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 634 Atypical Thymoma (Type B3 Thymoma) David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 642 Thymic Carcinoma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 652 Neuroendocrine Carcinomas of Thymus David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD GERM CELL TUMORS 660 Mediastinal Teratoma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 666 Mediastinal Seminoma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 670 Yolk Sac Tumor David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 676 Choriocarcinoma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 680 Embryonal Carcinoma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD HEMATOPOIETIC MALIGNANCIES 684 Hodgkin Lymphoma of Mediastinum David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 692 Diffuse Large Cell Lymphoma of Mediastinum David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 706 Lymphoblastic Lymphoma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 712 MALT Lymphoma of Thymus David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD MESENCHYMAL NEOPLASMS 716 Liposarcoma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 724 Leiomyosarcoma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 728 Synovial Sarcoma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 740 Malignant Peripheral Nerve Sheath Tumor David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 746 Solitary Fibrous Tumor David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 754 Epithelioid Hemangioendothelioma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 762 Mesenchymal Chondrosarcoma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 766 Chordoma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 772 Alveolar Soft Part Sarcoma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 776 Rhabdomyosarcoma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD SYMPATHETIC NERVOUS SYSTEM TUMORS 780 Ganglioneuroma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 784 Neuroblastoma/Ganglioneuroblastoma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 790 Ependymoma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD OTHER TUMORS 794 Ectopic Parathyroid Tumor David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 798 Ectopic Thyroid Tumor David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD OTHER BENIGN/REACTIVE CONDITIONS 802 Thymolipoma David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 806 Castleman Disease David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 812 Simple (Benign) Mediastinal Cysts David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 818 Acquired Multilocular Thymic Cyst David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD 826 Idiopathic Sclerosing Mediastinitis David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD

Read more less

Book SynopsisTable of ContentsSECTION 1: PERITONEUM AND MESENTERY GENERIC IMAGING PATTERNS 4 Mesenteric or Omental Mass (Solid) Siva P. Raman, MD 10 Mesenteric or Omental Mass (Cystic) Siva P. Raman, MD 14 Fat-Containing Lesion, Peritoneal Cavity Siva P. Raman, MD 18 Mesenteric Lymphadenopathy Siva P. Raman, MD 22 Abdominal Calcifications Siva P. Raman, MD 28 Pneumoperitoneum Siva P. Raman, MD 32 Hemoperitoneum Siva P. Raman, MD 36 Misty (Infiltrated) Mesentery Siva P. Raman, MD MODALITY-SPECIFIC IMAGING FINDINGS COMPUTED TOMOGRAPHY 42 High-Attenuation (Hyperdense) Ascites Siva P. Raman, MD SECTION 2: ABDOMINAL WALL ANATOMICALLY BASED DIFFERENTIALS 48 Abdominal Wall Mass Siva P. Raman, MD 52 Mass in Iliopsoas Compartment Siva P. Raman, MD 54 Groin Mass Siva P. Raman, MD 58 Elevated or Deformed Hemidiaphragm Siva P. Raman, MD 60 Defect in Abdominal Wall (Hernia) Siva P. Raman, MD SECTION 3: ESOPHAGUS GENERIC IMAGING PATTERNS 66 Intraluminal Mass, Esophagus Atif Zaheer, MD and Michael P. Federle, MD, FACR 68 Extrinsic Mass, Esophagus Atif Zaheer, MD and Michael P. Federle, MD, FACR 72 Lesion at Pharyngoesophageal Junction Atif Zaheer, MD and Michael P. Federle, MD, FACR 74 Esophageal Ulceration Atif Zaheer, MD and Michael P. Federle, MD, FACR 76 Mucosal Nodularity, Esophagus Atif Zaheer, MD and Michael P. Federle, MD, FACR 78 Esophageal Strictures Atif Zaheer, MD and Michael P. Federle, MD, FACR 80 Dilated Esophagus Atif Zaheer, MD and Michael P. Federle, MD, FACR 82 Esophageal Outpouchings (Diverticula) Atif Zaheer, MD and Michael P. Federle, MD, FACR 84 Esophageal Dysmotility Atif Zaheer, MD and Michael P. Federle, MD, FACR CLINICALLY BASED DIFFERENTIALS 86 Odynophagia Atif Zaheer, MD and Michael P. Federle, MD, FACR SECTION 4: STOMACH GENERIC IMAGING PATTERNS 90 Gastric Mass Lesions Atif Zaheer, MD and Michael P. Federle, MD, FACR 96 Intramural Mass, Stomach Atif Zaheer, MD and Michael P. Federle, MD, FACR 98 Target or Bull's-Eye Lesions, Stomach Atif Zaheer, MD and Michael P. Federle, MD, FACR 100 Gastric Ulceration (Without Mass) Atif Zaheer, MD and Michael P. Federle, MD, FACR 102 Intrathoracic Stomach Atif Zaheer, MD and Michael P. Federle, MD, FACR 104 Thickened Gastric Folds Atif Zaheer, MD and Michael P. Federle, MD, FACR 110 Gastric Dilation or Outlet Obstruction Atif Zaheer, MD and Michael P. Federle, MD, FACR 114 Linitis Plastica, Limited Distensibility Atif Zaheer, MD and Michael P. Federle, MD, FACR CLINICALLY BASED DIFFERENTIALS 118 Epigastric Pain Atif Zaheer, MD and Michael P. Federle, MD, FACR 124 Left Upper Quadrant Mass Atif Zaheer, MD and Michael P. Federle, MD, FACR SECTION 5: DUODENUM GENERIC IMAGING PATTERNS 130 Duodenal Mass Atif Zaheer, MD and Michael P. Federle, MD, FACR 136 Dilated Duodenum Atif Zaheer, MD and Michael P. Federle, MD, FACR 138 Thickened Duodenal Folds Atif Zaheer, MD and Michael P. Federle, MD, FACR SECTION 6: SMALL INTESTINE GENERIC IMAGING PATTERNS 142 Multiple Masses or Filling Defects, Small Bowel Atif Zaheer, MD and Michael P. Federle, MD, FACR 144 Cluster of Dilated Small Bowel Atif Zaheer, MD and Michael P. Federle, MD, FACR 146 Aneurysmal Dilation of Small Bowel Lumen Atif Zaheer, MD and Michael P. Federle, MD, FACR 148 Stenosis, Terminal Ileum Atif Zaheer, MD and Michael P. Federle, MD, FACR 150 Segmental or Diffuse Small Bowel Wall Thickening Atif Zaheer, MD and Michael P. Federle, MD, FACR 156 Pneumatosis of Small Intestine or Colon Atif Zaheer, MD and Michael P. Federle, MD, FACR CLINICALLY BASED DIFFERENTIALS 160 Occult GI Bleeding Atif Zaheer, MD and Michael P. Federle, MD, FACR 164 Small Bowel Obstruction Atif Zaheer, MD and Michael P. Federle, MD, FACR SECTION 7: COLON GENERIC IMAGING PATTERNS 172 Solitary Colonic Filling Defect Atif Zaheer, MD and Michael P. Federle, MD, FACR 174 Multiple Colonic Filling Defects Atif Zaheer, MD and Michael P. Federle, MD, FACR 176 Mass or Inflammation of Ileocecal Area Atif Zaheer, MD and Michael P. Federle, MD, FACR 182 Colonic Ileus or Dilation Atif Zaheer, MD and Michael P. Federle, MD, FACR 186 Toxic Megacolon Atif Zaheer, MD and Michael P. Federle, MD, FACR 188 Rectal or Colonic Fistula Atif Zaheer, MD and Michael P. Federle, MD, FACR 194 Segmental Colonic Narrowing Atif Zaheer, MD and Michael P. Federle, MD, FACR 198 Colonic Thumbprinting Atif Zaheer, MD and Michael P. Federle, MD, FACR 200 Colonic Wall Thickening Atif Zaheer, MD and Michael P. Federle, MD, FACR 206 Smooth Ahaustral Colon Atif Zaheer, MD and Michael P. Federle, MD, FACR CLINICALLY BASED DIFFERENTIALS 208 Acute Right Lower Quadrant Pain Atif Zaheer, MD and Michael P. Federle, MD, FACR 214 Acute Left Lower Quadrant Pain Atif Zaheer, MD and Michael P. Federle, MD, FACR SECTION 8: SPLEEN GENERIC IMAGING PATTERNS 222 Splenomegaly Siva P. Raman, MD 226 Multiple Splenic Calcifications Siva P. Raman, MD 228 Solid Splenic Mass or Masses Siva P. Raman, MD 230 Cystic Splenic Mass Siva P. Raman, MD MODALITY-SPECIFIC IMAGING FINDINGS COMPUTED TOMOGRAPHY 232 Diffuse Increased Attenuation, Spleen Siva P. Raman, MD SECTION 9: LIVER GENERIC IMAGING PATTERNS 236 Liver Mass With Central or Eccentric Scar Atif Zaheer, MD and Michael P. Federle, MD, FACR 240 Focal Liver Lesion With Hemorrhage Atif Zaheer, MD and Michael P. Federle, MD, FACR 244 Liver "Mass" With Capsular Retraction Atif Zaheer, MD and Michael P. Federle, MD, FACR 246 Fat-Containing Liver Mass Atif Zaheer, MD and Michael P. Federle, MD, FACR 248 Cystic Hepatic Mass Atif Zaheer, MD and Michael P. Federle, MD, FACR 252 Focal Hypervascular Liver Lesion Atif Zaheer, MD and Michael P. Federle, MD, FACR 258 Liver Mass With Mosaic Enhancement Atif Zaheer, MD 262 Mosaic or Patchy Hepatogram Atif Zaheer, MD and Michael P. Federle, MD, FACR 266 Hepatic Calcifications Atif Zaheer, MD and Michael P. Federle, MD, FACR 270 Liver Lesion Containing Gas Atif Zaheer, MD and Michael P. Federle, MD, FACR 274 Portal Venous Gas Atif Zaheer, MD and Michael P. Federle, MD, FACR 276 Widened Hepatic Fissures Atif Zaheer, MD and Michael P. Federle, MD, FACR 278 Dysmorphic Liver With Abnormal Bile Ducts Atif Zaheer, MD and Michael P. Federle, MD, FACR 282 Focal Hyperperfusion Abnormality (THAD or THID) Atif Zaheer, MD and Michael P. Federle, MD, FACR MODALITY-SPECIFIC IMAGING FINDINGS MAGNETIC RESONANCE IMAGING 288 Multiple Hypodense Liver Lesions Atif Zaheer, MD and Michael P. Federle, MD, FACR 294 Multiple Hypointense Liver Lesions (T2WI) Atif Zaheer, MD and Michael P. Federle, MD, FACR 298 Hyperintense Liver Lesions (T1WI) Atif Zaheer, MD and Michael P. Federle, MD, FACR 304 Liver Lesion With Capsule or Halo on MR Atif Zaheer, MD and Michael P. Federle, MD, FACR COMPUTED TOMOGRAPHY 308 Focal Hyperdense Hepatic Mass on Nonenhanced CT Atif Zaheer, MD and Michael P. Federle, MD, FACR 312 Periportal Lucency or Edema Atif Zaheer, MD and Michael P. Federle, MD, FACR 318 Widespread Low Attenuation Within Liver Atif Zaheer, MD and Michael P. Federle, MD, FACR ULTRASOUND 322 Focal Hepatic Echogenic Lesion ± Acoustic Shadowing Atif Zaheer, MD, Gregory E. Antonio, MD, DRANZCR, FHKCR, and Eric K. H. Liu, PhD, RDMS 328 Hyperechoic Liver, Diffuse Atif Zaheer, MD, Gregory E. Antonio, MD, DRANZCR, FHKCR, and Eric K. H. Liu, PhD, RDMS 330 Hepatomegaly Hee Sun Park, MD, PhD and Aya Kamaya, MD, FSRU, FSAR 334 Diffuse Liver Disease Hee Sun Park, MD, PhD and Aya Kamaya, MD, FSRU, FSAR 336 Cystic Liver Lesion Hee Sun Park, MD, PhD and Aya Kamaya, MD, FSRU, FSAR 340 Hypoechoic Liver Mass Hee Sun Park, MD, PhD and Aya Kamaya, MD, FSRU, FSAR 344 Echogenic Liver Mass Hee Sun Park, MD, PhD and Aya Kamaya, MD, FSRU, FSAR 348 Target Lesions in Liver Hee Sun Park, MD, PhD and Aya Kamaya, MD, FSRU, FSAR 350 Multiple Hepatic Masses Hee Sun Park, MD, PhD and Aya Kamaya, MD, FSRU, FSAR 354 Hepatic Mass With Central Scar Hee Sun Park, MD, PhD and Aya Kamaya, MD, FSRU, FSAR 356 Periportal Lesion Hee Sun Park, MD, PhD and Aya Kamaya, MD, FSRU, FSAR 360 Irregular Hepatic Surface Aya Kamaya, MD, FSRU, FSAR 362 Portal Vein Abnormality Hee Sun Park, MD, PhD and Aya Kamaya, MD, FSRU, FSAR SECTION 10: GALLBLADDER GENERIC IMAGING PATTERNS 366 Distended Gallbladder Siva P. Raman, MD 368 Gas in Bile Ducts or Gallbladder Siva P. Raman, MD 372 Focal Gallbladder Wall Thickening Siva P. Raman, MD 374 Diffuse Gallbladder Wall Thickening Jade Wong-You-Cheong, MBChB, MRCP, FRCR, FSRU, FSAR MODALITY-SPECIFIC IMAGING FINDINGS COMPUTED TOMOGRAPHY 378 High-Attenuation (Hyperdense) Bile in Gallbladder Siva P. Raman, MD ULTRASOUND 380 Hyperechoic Gallbladder Wall Jade Wong-You-Cheong, MBChB, MRCP, FRCR, FSRU, FSAR 382 Echogenic Material in Gallbladder Jade Wong-You-Cheong, MBChB, MRCP, FRCR, FSRU, FSAR 384 Dilated Gallbladder Jade Wong-You-Cheong, MBChB, MRCP, FRCR, FSRU, FSAR 388 Intrahepatic and Extrahepatic Duct Dilatation L. Nayeli Morimoto, MD and Aya Kamaya, MD, FSRU, FSAR CLINICALLY BASED DIFFERENTIALS 390 Right Upper Quadrant Pain Siva P. Raman, MD SECTION 11: BILIARY TRACT GENERIC IMAGING PATTERNS 398 Dilated Common Bile Duct Siva P. Raman, MD 404 Asymmetric Dilation of Intrahepatic Bile Ducts Siva P. Raman, MD 408 Biliary Strictures, Multiple Siva P. Raman, MD MODALITY-SPECIFIC IMAGING FINDINGS MAGNETIC RESONANCE IMAGING 412 Hypointense Lesion in Biliary Tree (MRCP) Siva P. Raman, MD SECTION 12: PANCREAS GENERIC IMAGING PATTERNS 416 Hypovascular Pancreatic Mass Siva P. Raman, MD 422 Hypervascular Pancreatic Mass Siva P. Raman, MD 426 Cystic Pancreatic Mass Siva P. Raman, MD 432 Atrophy or Fatty Replacement of Pancreas Siva P. Raman, MD 434 Dilated Pancreatic Duct Siva P. Raman, MD 438 Infiltration of Peripancreatic Fat Planes Siva P. Raman, MD 444 Pancreatic Calcifications Siva P. Raman, MD MODALITY-SPECIFIC IMAGING FINDINGS ULTRASOUND 448 Cystic Pancreatic Lesion Fauzia Vandermeer, MD 452 Solid Pancreatic Lesion Fauzia Vandermeer, MD 456 Pancreatic Duct Dilatation Fauzia Vandermeer, MD SECTION 13: RETROPERITONEUM GENERIC IMAGING PATTERNS 460 Retroperitoneal Mass, Cystic Matthew T. Heller, MD, FSAR 466 Retroperitoneal Mass, Soft Tissue Density Matthew T. Heller, MD, FSAR 472 Retroperitoneal Mass, Fat Containing Matthew T. Heller, MD, FSAR 474 Retroperitoneal Hemorrhage Matthew T. Heller, MD, FSAR SECTION 14: ADRENAL GENERIC IMAGING PATTERNS 478 Adrenal Mass Mitchell Tublin, MD SECTION 15: KIDNEY GENERIC IMAGING PATTERNS 486 Solid Renal Mass Mitchell Tublin, MD 490 Cystic Renal Mass Mitchell Tublin, MD 494 Bilateral Renal Cysts

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

Book Synopsis

Read more less

Book SynopsisDrugs in Use: Case Studies for Pharmacists and Prescribers helps you to bridge the gap between theoretical knowledge about medicines and the practical application to your patients. With an ever increasing shift of focus from theory to practice this book promotes evidence-based medicine and illustrates how you can optimise drug therapy in response to the needs of your individual patients. It will prove a valuable resource to pharmacists and prescribers. The cases have been updated to reflect recent changes in medicines use and this new edition boasts: New evidence concerning optimal care; Additional coverage of situations with difficulties in treatment optimisation; Significant focus on major advances in therapeutics; Self study questions and answers within each case. With self study questions and answers to accompany each case, you will find this a useful resource throughout your career. As a student, it will assist your studies and as a practicing pharmacist or prescriber in hospitalTrade Review"Drugs In Use" focuses on clinical skills, and that is a very useful area for modern pharmacists, both in hospital as well as community... When I was scanning through the book, I got 'stuck' easily by the instructive and fascinating case descriptions...I was learning new things, and this probably is the strength of the book. It helps to translate abstract knowledge into applicable clinical expertise... A good read for pharmacists who are interested in pharmacotherapy." J.W.F. van Mil, International Journal of Clinical Pharmacy, 36(469), 2014. -- J.W.F. van Mil * International Journal of Clinical Pharmacy *"Pharmacy students can benefit from practicing their skills and formulating their own opinion...pharmacists can maintain clinical competencies by resolving these scenarios...written by pharmacists with considerable experience...5 stars!" Melissa M. Ranieri, BS, PharmD(Temple University School of Pharmacy), Doody's Notes, 2013. -- Melissa M. Ranieri * Doody's Notes *"This book provides evidence-based medicine and illustrates how one can optimize drug therapy in response to the needs of individual patients...This is a very interesting and applicable book for pharmacy practice today." Compounding Today, 10(27) 5 July 2013. * Compounding Today *Table of ContentsHypertension; Ischaemic Heart Disease; Myocardial Infarction; Cardiac Failure; Stroke; Type I Diabetes in Childhood; Type II Diabetes Mellitus; Acute Renal Failure; Chronic Renal Failure Managed By Automated Peritoneal Dialysis; Renal Transplantation; Asthma; Chronic Obstructive Pulmonary Disease; Peptic Ulcer; Crohn's Disease; Alcoholic Liver Disease; Rheumatoid Arthritis; Osteoporosis; Epilepsy; Parkinson's Disease; Depression; Schizophrenia; Dementia; Substance Misuse; Human Immunodeficiency (HIV) Disease: Opportunistic Infections and Antiretroviral Therapy; Oncology; Symptom Control in Palliative Care; Eczema; Psoriasis; Anticoagulant Therapy; Colorectal Surgery; Cholecystectomy; Medicines Management; Managing Medicine Risk.

Read more less

Book SynopsisMinor Illness or Major Disease is a well-established undergraduate textbook covering the diagnosis and management of the illnesses and diseases frequently encountered in community pharmacy practice.Trade ReviewThis latest edition offers a new approach to the management of minor illness, the most obvious difference from previous editions being the reformatting of the book to mirror the structure of the British National Formulary. The book also uses the problem-based learning approach where minor illnesses are discussed in the context of case studies. A pharmacist and a general medical practitioner or dietitian responds to the case. This illustrates the similarities and differences in approach by two different healthcare professionals. Each chapter ends with a series of self-assessment questions, the styles of which reflect those encountered in university or professional examinations. The book is well structured and easy to use. The tables are clear and concise and the photographs and illustrations are of the highest quality. It should be read by pharmacy undergraduates and preregistration trainees, and it will also be of great value to community pharmacists. -- Laurence A. Goldberg * The Pharmaceutical Journal *The latest incarnation of such a valuable text comes courtesy of the well-established and renowned Pharmacy Practice team at Robert Gordons University Aberdeen... Differential diagnostic reasoning is presented throughout the chapter text, thereby allowing the reader to feel better informed when they ask that question of themselves - "Is this a Minor Illness or a Major Disease?" - when confronted with any clinical presentation... Text presentation is clear, concise and well delivered, with the result that the book itself represents an easily-accessible reference resource for the reader which can be cross-referenced with the BNF... The sixth edition of Minor Illness or Major Disease provides us with a timely update to what is already a stalwart within the Community Pharmacy practice resource library. -- Noel Stenson * Irish Pharmacy Union *Table of Contents1. Introduction2. Gastrointestinal Illnesses3. Respiratory Illnesses4. Central Nervous System 5. Infections and Infestations6. Obstetrics, Gynaecology and Urinary System7. Eyes, Ears and Oral Health8. Nutrition9. Dermatology

Read more less

Book SynopsisDiagnostic Lymph Node Pathology presents a logical and systematic approach to lymph node biopsies and guides general pathologists and haematopathologists alike through the maze of differential diagnoses, enabling them to reach an accurate diagnosis.The book is presented in an easy-to-read format and contains boxes for quick reference detailing the clinical, morphological, immunohistochemical, and genetic features of each entity. Thoroughly revised, the third edition also includes more than 300 high-quality histological colour photographs along with updated references.This edition covers both classical and less well-known features of individual disease processes. It is a valuable guide for both professionals and trainees. Trade ReviewPraise for the First Edition"... The chapters are well proportioned with succinct, lucid and reader-friendly text. The lesions are generously illustrated and all the photographs (H&E, immunostains and electron micrographs) are of superb quality."—HistopathologyTable of ContentsHandling of Lymph Node Biopsies, Diagnostic Procedures and Recognition of Lymph Node Patterns. Normal/Reactive Lymph Nodes: Structure and Cells. Reactive and Infective Lymphadenopathy. Precursor B- and T-Cell Lymphomas. Mature B-Cell Lymphomas. T-Cell Lymphomas. Immunodeficiency-Associated Lymphoproliferative Disorders. Hodgkin Lymphoma. Histiocytic and Dendritic Cell Neoplasms, Mastocytosis and Myeloid Sarcoma. Non-Haematolymphoid Tumours of Lymph Nodes. Needle (Trephine) Core Biopsies of Lymph Nodes. Appendix: Immunohistochemical Markers Used in Diagnosis of Lymphoproliferative Conditions.

Read more less

Book SynopsisNucleic Acid Testing for Human Disease describes various techniques including target and signal amplification-based NAT procedures, microarrays, bead-based multiplex assays, in situ hybridization, and SNP techniques. This book discusses RNA expression profiling and laboratory issues such as the need for proper validation of tests intended for routine use. It focuses on specific applications of NATs to human disease diagnosis and treatment, from viral, bacterial, fungal, and protozoan detection to genetic exploration by SNP determinations, patterns of RNA expression, and the growing relevance of epigenetic changes. It also offers different perspectives on future directions in the field.Table of ContentsNucleic acid diagnostic technology. Target Amplification-Based Techniques. Signal Amplification-Based Techniques. Microarrays: Human Disease Detection and Monitoring. Bead-Based Flow Systems: From Centralized Laboratories to Genetic Testing in the Field. In situ Hybridization. SNP Detection Techniques. RNA Expression Profiling. Evolution of the Molecular Microbiology Laboratory. Disease applications of NAT tests. Bacterial STDs. Sexually Transmissible Viral Pathogens: The Human Papillomaviruses and Herpes Simplex Viruses. Blood-Borne Viruses in Clinical and Diagnostic Virology. Molecular Methods for the Diagnosis of Fungal Infections. Molecular Diagnostic Approaches in Infectious Disease. Cancer Detection and Prognosis. Common Inherited Genetic Disorders. Bridging the Gap Between Analytical and Clinical Validation. Future Perspectives on Nucleic Acid Testing. Index.

Read more less

Book Synopsis

Read more less

Book SynopsisAs the title suggests this book has been written to assist manual therapists to understand and hone the palpatory skills which are essential to their effectiveness as practitioners. Skilful palpation is the foundation stone of all effective manual therapy assessments and treatments. The ability to use subtle and sensitive touch to examine and assess patients is essential for an accurate interpretation of the underlying problems of fascial and muscle function. The accurate interpretation of palpatory findings is difficult and comes with experience. This book aims to increase awareness of how to palpate and understanding of what is being felt.In this fourth edition of his now well-established and much loved book Leon Chaitow has introduced references to the latest research findings relating to fascia and its role in health and disease, so that practitioners can apply this knowledge in interpreting what they palpate. In addition to the author, six notable contributors from Europe and North America enhance the work''s range and authority.All manual therapists, whatever their professional background, will benefit from the wealth of experience- and research-based information presented in this book.

Read more less

Book SynopsisHighlights the importance and benefit of mass spectrometry-based metabolomics for identifying biomarkers that accurately screen for potential biomarkers of diseases Mass spectrometry-based metabolomics offer new opportunities for biomarker discovery in complex diseases and may provide pathological understanding of diseases beyond traditional technologies. It is the systematic analysis of low-molecular-weight metabolites in biological samples and has been applied to discovering and identifying the perturbed pathways. Currently, mass spectrometry-based metabolomics has become an important tool in clinical research and the diagnosis of human disease. Mass Spectrometry-Based Metabolomics in Clinical and Herbal Medicines comprehensively presents the current state, challenges, and applications of high-throughput mass spectrometry-based metabolomics such as metabolites analysis, biomarker discovery, technical challenges, discovery of natural product, mechanism interpretation of action, discovery of active ingredients, clinical application and precision medicine, and enhancing their biomedical value in a real world of biomedicine, shedding light on the potential for spectrometry-based metabolomics. It highlights the value of mass spectrometry-based metabolomics and metabolism to address the complexity of herbal medicines in systems pharmacology, especially, to link phytochemical analysis with the assessment of pharmacological effect and therapeutic potential. Each chapter has been laid out with introduction, method, up-to-date literature, identification of biomarker, and applications Covers the current state, challenges, and applications of high-throughput mass spectrometry-based metabolomics in the discovery of biomarker, active ingredients, natural product, etc. Constitutes a unique and indispensable practical guide for any phytochemistry or related laboratory, and provides hands-on description of new techniques Provides a guide for new practitioners of pharmacologists, pharmacological scholars, drug developers, botanist, researchers of traditional medicines. Mass Spectrometry-Based Metabolomics in Clinical and Herbal Medicines provides a landmark of mass spectrometry-based metabolomics research and a beneficial guideline to graduate students and researchers in academia, industry, and technology transfer organizations in all biomedical science fields.Table of ContentsPreface xiii 1 Current State of the Art of High-Throughput Metabolomics 1Aihua Zhang, Qiang Yang, Hui Sun, and Xijun Wang 1.1 Introduction 1 1.2 Metabolomics 1 1.3 Mass Spectrometry Technology 2 1.4 Recent Advancements and Applications 4 1.4.1 Disease Diagnoses and Metabolism 4 1.4.2 Metabolic Mechanisms 6 1.4.3 Drug Efficacy 7 1.4.4 Nutrition 7 1.4.5 Plant Biology 8 1.5 Limitation 8 1.6 Conclusions and Future Perspectives 9 Acknowledgments 9 References 9 2 Innovations in Analytical Techniques of Metabolomics 19Ling Kong, Aihua Zhang, Shi Qiu, and Xijun Wang 2.1 Introduction 19 2.2 Current Analytical Technologies of Metabolomics 20 2.3 Chromatography Platform 21 2.3.1 Gas Chromatography Technique 21 2.3.2 Liquid Chromatography Technique 21 2.3.3 Supercritical Fluid Chromatography Technique 22 2.3.4 Capillary Electrophoresis Chromatography Technique 22 2.4 Mass Spectrometry Platform 23 2.4.1 GC–MS Technique 23 2.4.2 LC–MS Technique 24 2.4.3 SFC–MS Technique 24 2.4.4 CE–MS Technique 24 2.5 Nuclear Magnetic Resonance Platform 25 2.6 Comprehensive and Multidimensional Analytical Platform 25 2.7 Conclusions 25 Acknowledgments 26 References 26 3 Sample Preparation Method for Mass Spectrometry-Based Metabolomics 33Shi Qiu, Aihua Zhang, Hui Sun, and Xijun Wang 3.1 Introduction 33 3.2 Sample Collection and Storage 34 3.2.1 Urine 34 3.2.2 Plasma and Serum 35 3.2.3 Cerebrospinal Fluids 35 3.2.4 Tissue Homogenates 35 3.2.5 Saliva 36 3.3 Sample Preparation and Processing 36 3.4 Application 37 3.5 Future Development 38 Acknowledgments 38 References 38 4 Multivariate Data Analysis Approach for Mass Spectrometry-Based Metabolomics 45Junling Ren, Aihua Zhang, Ling Kong, and Xijun Wang 4.1 Introduction 45 4.2 Separation-Based MS Techniques 46 4.2.1 Gas Chromatography–Mass Spectrometry 46 4.2.2 Liquid Chromatography–Mass Spectrometry 46 4.2.2.1 Reversed-Phase Liquid Chromatography–Mass Spectrometry 47 4.2.2.2 Hydrophilic Interaction Chromatography–Mass Spectrometry 47 4.2.2.3 Supercritical Fluid Chromatography–Mass Spectrometry 48 4.2.3 Capillary Electrophoresis–Mass Spectrometry 48 4.2.4 Ion Mobility–Mass Spectrometry 49 4.3 Separation-Free MS Techniques 49 4.3.1 Direct Infusion–Mass Spectrometry 49 4.3.2 Matrix-Assisted Laser Desorption Ionization–Mass Spectrometry 50 4.3.3 Mass Spectrometry Imaging 50 4.3.4 Direct Analysis in Real Time–Mass Spectrometry 51 4.4 Tools for MS Result Analysis 51 4.5 Multivariate Statistical Analysis Approach for Data Analysis 53 4.6 Limitations and Challenges 57 4.7 Conclusions and Future Perspectives 58 Acknowledgments 60 References 60 5 Mass Spectrometry-Driven Metabolomics for Metabolites and Metabolic Pathway Analysis 67Aihua Zhang, Hui Sun, Shi Qiu, and Xijun Wang 5.1 Introduction 67 5.2 Mass Spectrometry-Driven Metabolomics for Biomarker Discovery 69 5.3 Data Extraction and Analysis for Metabolites and Metabolic Pathway 69 5.4 Biomarker Identification 70 5.5 Applications 70 5.6 Conclusions 73 Acknowledgments 73 References 73 6 Metabolomics as Drivers for Biomarker Discovery and Mechanism Interpretation 81Wanying Wang, Aihua Zhang, Hui Sun, Guangli Yan, and Xijun Wang 6.1 Introduction 81 6.2 Metabolomics for Biomarker Discovery 82 6.3 Metabolomics for Mechanism Interpretation 83 6.4 Application 85 6.5 Current Trends and Future Perspectives 88 6.6 Conclusions 89 Acknowledgments 89 References 89 7 Current Status of Technical Challenges in Mass Spectrometry-Driven Metabolomics 97Shi Qiu, Aihua Zhang, Hui Sun, and Xijun Wang 7.1 Introduction 97 7.2 Metabolic Fingerprinting and Profiling 98 7.3 Non-targeted or Targeted Metabolomics 99 7.4 Metabolite Identification Bottleneck 99 7.5 Quality Control Bottleneck 101 7.6 Mass Spectrometry Techniques 102 7.6.1 LC–MS 102 7.6.2 GC–MS 103 7.6.3 NMR–MS 104 7.7 Prospects 105 7.8 Conclusions 105 Acknowledgments 105 References 106 8 The Application of Metabolomics in Cancer Management 113Aihua Zhang, Hui Sun, and Xijun Wang 8.1 Introduction 113 8.2 Epidemiology and Diagnosis 114 8.3 Prospective Biomarkers 114 8.4 Metabolomics Screening Biomarkers 117 8.5 Conclusions and Future Directions 117 Acknowledgments 118 References 118 9 Metabolomics in Coronary Heart Disease: From Biomarker Identification to Pathomechanism Insights 123Hui Sun, Aihua Zhang, Shi Qiu, and Xijun Wang 9.1 Introduction 123 9.2 Predicament 126 9.3 Metabolomics for CHD 126 9.4 Biomarker Dilemma 127 9.5 Lipid Metabolism 128 9.6 Treatment of Herbal Medicine 128 9.7 Conclusions and Future Direction 129 Acknowledgments 129 References 130 10 Metabolomics Applications in Neurological Disease 135Shi Qiu, Ying Han, Aihua Zhang, Hui Sun, and Xijun Wang 10.1 Introduction 135 10.2 CSF Sampling 136 10.3 Application of Metabolomics in CNS 136 10.4 Future Direction 137 10.5 Conclusions 138 Acknowledgments 139 References 139 11 Metabolomics Toward Precision Medicine 143Aihua Zhang, Shi Qiu, Hui Sun, Guangli Yan, and Xijun Wang 11.1 Introduction 143 11.2 Precision Medicine: A New Era of Medicine 144 11.3 Precision Biomarkers 145 11.4 Metabolomics as a Powerful Tool for Potential Biomarkers 146 11.5 Practical Application of Metabolomics 147 11.6 Precision Medicine for Herbal Medicine 148 11.7 Conclusions and Future Perspectives 150 Acknowledgments 151 References 151 12 Mass Spectrometry-Based Metabolomics Toward Biological Function Analysis 157Shi Qiu, Wanying Wang, Aihua Zhang, and Xijun Wang 12.1 Introduction 157 12.2 Current Trend and Challenge of Disease Phenotype 158 12.3 Advances in Mass Spectrometry Analytic Technique 158 12.4 Advantages of Mass Spectrometry-Based Metabolomics 159 12.5 Mass Spectrometry-Based Metabolomics for Biological Function 159 12.6 Limitations of MS-Based Metabolomics 165 12.7 Future Perspectives 165 12.8 Conclusions 166 Acknowledgments 166 References 166 13 Mass Spectrometry-Driven Active Ingredients Discovery from Herbal Medicine 171Wanying Wang, Aihua Zhang, Shi Qiu, and Xijun Wang 13.1 Introduction 171 13.2 An Overview of Herbal Medicine 172 13.3 Mass Spectrometry to Identify the Chemical Constituents 173 13.4 Mass Spectrometry for Constituent Analysis In Vivo 173 13.5 Mass Spectrometry-Based Chinmedomics Strategy 175 13.6 Application 175 13.7 Conclusions and Future Perspectives 176 Acknowledgments 177 References 177 14 Metabolomics Application in Herbal Medicine 185Wanying Wang, Aihua Zhang, Hui Sun, and Xijun Wang 14.1 Introduction 185 14.2 Metabolomic Dissection of Herbal Medicine 186 14.3 Application in Herbal Medicine 189 14.3.1 Effect Evaluations 189 14.3.2 Mechanism Explorations 192 14.3.3 Quality Control Analyses 193 14.4 Conclusions 194 Acknowledgments 194 References 194 15 Mass Spectrometry-Based Metabolomics Insights into the Mode of Action of Natural Products 199Junling Ren, Aihua Zhang, Hui Sun, and Xijun Wang 15.1 Introduction 199 15.2 Metabolomics: An Overview 200 15.2.1 Comprehensive Metabolomics for Metabolites Detection 200 15.2.2 Understanding Pharmacological Effects 200 15.2.3 Discovery of Biomarkers and Targets 201 15.2.4 Screen Bioactive Natural Products 201 15.3 Superiority of MS-Based Metabolomics 201 15.3.1 Enhanced MS Coverage for Small-Molecule Metabolites 202 15.3.2 MS-Based Metabolomics Guided Biochemical Analysis 202 15.3.3 Identify Molecular Mechanisms by Integrating MS with Databases 202 15.4 Mass Spectrometry Techniques Employed in Metabolomics 202 15.4.1 Gas Chromatography–Mass Spectrometry 203 15.4.2 Liquid Chromatography–Mass Spectrometry 203 15.4.3 Capillary Electrophoresis–Mass Spectrometry 203 15.4.4 Ion Mobility–Mass Spectrometry 204 15.4.5 Mass Spectrometry Imaging 204 15.4.6 New Challenges in MS-Based Metabolomics 204 15.5 Challenges of Natural Products 205 15.6 Herbal Ingredients: Current Research and Applications 205 15.6.1 Various Analytical Strategies for Herbal Ingredients 205 15.6.2 Effective Constituents In Vitro and In Vivo 206 15.7 MS in Natural Product 206 15.7.1 Qualitative Analysis 206 15.7.2 Quantitative Analysis 207 15.7.3 Mechanism Analysis of Action 207 15.8 MS-Based Metabolomics in Bioactive Ingredients 208 15.8.1 Reveal Efficacy of HMs 208 15.8.2 High-Throughput Analysis of HMs 209 15.8.3 Discovery of Quality Markers 209 15.8.4 Toxicity Explorations 211 15.8.5 Potential Impacts on Drug Discovery 211 15.9 Conclusions and Future Perspective 212 Acknowledgment 212 References 213 16 Mass Spectrometry-Driven Lipidomics for Biomarker, Molecular Mechanism, and Therapy 223Qiang Yang, Shi Qiu, Aihua Zhang, and Xijun Wang 16.1 Introduction 223 16.2 Lipidomics Method 223 16.2.1 Targeted Lipidomics 224 16.2.2 Non-targeted Lipidomics 225 16.3 Sample Preparation 225 16.4 Analytical Techniques in Lipidomics 227 16.4.1 Liquid Chromatography–Mass Spectrometry 227 16.4.2 Gas Chromatography–Mass Spectrometry 228 16.4.3 Supercritical Fluid Chromatography–Mass Spectrometry 228 16.4.4 Ion Mobility–Mass Spectrometry 228 16.4.5 Mass Spectrometry Imaging 229 16.4.6 Shotgun Lipidomics 229 16.5 Lipidomics for Biomarker Discovery 229 16.6 Application of MS-Based Lipidomics 230 16.6.1 Efficacy Analysis 230 16.6.2 Food Science 231 16.6.3 Environment 231 16.6.4 Clinical Biomarker Discovery 232 16.6.5 Pharmacological Research 232 16.6.6 Toxicology Analysis 232 16.7 Future Perspectives 233 16.8 Conclusions 234 Acknowledgments 234 References 234 17 Potential Application of Mass Spectrometry-Based Lipidomics for Herbal Medicine 245Ying Cai, Aihua Zhang, Hui Sun, and Xijun Wang 17.1 Introduction 245 17.2 Lipidomics Method 246 17.2.1 Sample Preparation 246 17.2.1.1 Classical Method 246 17.2.1.2 Green Technologies 247 17.2.2 Data Collection and Analysis of Lipidomics 248 17.2.2.1 Untargeted Lipidomics 248 17.2.2.2 Targeted Lipidomics 249 17.2.2.3 Pseudotargeted Lipidomics 249 17.3 Mass Spectrometry Technique in Lipidomics 250 17.3.1 Ionization Technology 250 17.3.2 Mass Analyzer 251 17.3.3 Tandem Mass Spectrometry 252 17.3.4 Ion Mobility–Mass Spectrometry 252 17.3.5 Mass Spectrometry Imaging 253 17.4 Application of Mass Spectrometry-Based Lipidomics for Herbal Medicine 253 17.5 Conclusions 255 Acknowledgments 255 References 255 Index 263

Read more less

Book SynopsisTrade Review"Autistic Intelligence: Interaction, Individuality, and the Challenges of Diagnosis proposes and characterizes a way of understanding autistic strengths, based on research conducted in two decades: the mid-1980s and the mid-2010s . . . Autistic Intelligence is rich with stories and very readable . . . [It] richly unpacks these stories and provides tools for perhaps remaking them." * Social Service Review *“A creative and original ethnographic study of a clinic at which developmental disabilities are diagnosed. Maynard and Turowetz introduce new analytical tools to understand the nature and varieties of autistic intelligence.” -- Mitchell Duneier, Princeton University"An authoritative challenge to conventional public and expert orientations toward autism, this is an ethnography about meaning-making that is brilliant in its own way.” -- Harvey Molotch, New York University"In Autistic Intelligence: Interaction, Individuality, and the Challenges of Diagnosis, Maynard and Turowetz offer a detailed and caring investigation of the autism diagnostic process. Drawing on a wealth of data and personal experience with autism spectrum disorders, the authors argue for expanding everyday interactional repertoires to enable intersubjectivity (co-meaning making) with autistic people, increasing the flexibility of the commonsense repertoires we all use to navigate the world." -- Alexandra H. Vinson * Symbolic Interaction *Table of ContentsChapter 1: Common Sense and the Interaction Order of the Clinic Chapter 2: A Brief History and Biology of Autism Diagnosis: Why We Need an Interactional Approach Chapter 3: An Interactional Entrance to Autism Diagnosis Chapter 4: Autistic Intelligence as Uncommon Sense Chapter 5: Varieties of Autistic Intelligence Chapter 6: Doing Diagnosis: Narrative Structure Chapter 7: Is Autism Real? Chapter 8: Interaction and the Particular Autistic Person Acknowledgments Notes References Index

Read more less

Book SynopsisTrade Review"Autistic Intelligence: Interaction, Individuality, and the Challenges of Diagnosis proposes and characterizes a way of understanding autistic strengths, based on research conducted in two decades: the mid-1980s and the mid-2010s . . . Autistic Intelligence is rich with stories and very readable . . . [It] richly unpacks these stories and provides tools for perhaps remaking them." * Social Service Review *“A creative and original ethnographic study of a clinic at which developmental disabilities are diagnosed. Maynard and Turowetz introduce new analytical tools to understand the nature and varieties of autistic intelligence.” -- Mitchell Duneier, Princeton University"An authoritative challenge to conventional public and expert orientations toward autism, this is an ethnography about meaning-making that is brilliant in its own way.” -- Harvey Molotch, New York University"In Autistic Intelligence: Interaction, Individuality, and the Challenges of Diagnosis, Maynard and Turowetz offer a detailed and caring investigation of the autism diagnostic process. Drawing on a wealth of data and personal experience with autism spectrum disorders, the authors argue for expanding everyday interactional repertoires to enable intersubjectivity (co-meaning making) with autistic people, increasing the flexibility of the commonsense repertoires we all use to navigate the world." -- Alexandra H. Vinson * Symbolic Interaction *Table of ContentsChapter 1: Common Sense and the Interaction Order of the Clinic Chapter 2: A Brief History and Biology of Autism Diagnosis: Why We Need an Interactional Approach Chapter 3: An Interactional Entrance to Autism Diagnosis Chapter 4: Autistic Intelligence as Uncommon Sense Chapter 5: Varieties of Autistic Intelligence Chapter 6: Doing Diagnosis: Narrative Structure Chapter 7: Is Autism Real? Chapter 8: Interaction and the Particular Autistic Person Acknowledgments Notes References Index

Read more less

Book SynopsisTraces the cultural context and wider social impact of such medical imaging practices as X ray and endoscopy, ultrasound imaging of fetuses, the filming and broadcasting of surgical operations, the creation of plastinated corpses for display as art objects, and the use of digitized cadavers in anatomical study.Trade Review"[A] forceful and haunting critique." * JAS Review of Books *Table of ContentsPreface Acknowledgments 1. Mediated Bodies and the Ideal of Transparency 2. The Operation Film as a Mediated Freak Show 3. Bodyworlds: The Art of Pastinated Cadavers 4. Fantastic Voyages in the Age of Endoscopy 5. X-ray Vision in Thomas Mann's The Magic Mountain 6. Ultrasound and the Visible Fetus 7. Digital Cadavers and Virtual Dissection Epilogue Notes Bibliography Index

Read more less

Book SynopsisCompetency-Based Assessments in Mental Health Practice should be required reading for all clinical practitioners and students. Author Susan W. Gray provides a competency-based assessment model that moves away from looking at mental illness as a ''disease'' to capturing people''s strengths and the uniqueness of their experience with mental illness. Alex Gitterma Zachs Professor and Director of PhD Program Competency-Based Assessment in Mental Health Practice not only describes the rather cumbersome DSM-IV-TR in a manner that graduate students and clinicians can easily understand and apply, but it also presents a competency-based type of clinical assessment that most effectively integrates the social work practice orientation that acknowledges, appreciates, and nurtures client strengths, resilience, and client ability for empowerment. Agathi Glezakos, PhD, LCSW School of Social Work Table of ContentsPreface. Acknowledgments. About the Author. 1 An Introduction to the Competency-Based Assessment. Perspectives on the Assessment. Overview of the Diagnostic and Statistical Manual of Mental Disorders. Setting the Stage for Competency-Based Assessments. The Competency-Based Assessment. The Partnership with Strengths, Empowerment and Resilience. Summary. 2 Formulating the Competency-Based Assessment Process: Some Basics. Introduction. Understanding the Case Studies. Formulating the Competency-Based Assessment. The Competency-based Assessment. Formulating the Competency-Based Assessment. The Competency-Based Assessment for Agnes Absinthe. Assessment Guidelines. Summary. 3 Disorders in Infancy, Childhood, or Adolescence. Introduction. Overview of the Major Characteristics of the Diagnostic Classifications. Incidence and Prevalence. The Pervasive Developmental Disorders. Beginning With Autistic Disorder. Autistic Disorder. Beginning With Asperger’s Disorder. Asperger's Disorder. The Attention Deficit and Disruptive Behavior Disorders. Attention-Deficit/Hyperactivity Disorder. Tic Disorders. The Elimination Disorders. Other Disorders. Beginning With Selective Mutism. Separation Anxiety. Final Thoughts. Practicing the Competency-Based Assessment. Practical Applications. Appendix: Competency-Based Assessments for Chapter 3 Case Examples: Listing of Case Diagnoses. Case Review for Anthony Moretti. Case Review for Paulie Merkel. 4 The Cognitive Disorders: Delirium and Dementia. Introduction. Incidence and Prevalence. Overview of the Major Characteristics of the Diagnostic Classifications. Delirium. Beginning With Dementia. Dementia. Beginning With Amnestic Disorder (Amnesia). Amnestic Disorder. Final Thoughts. Practicing the Competency-Based Assessment. Practical Applications. Appendix: Competency-Based Assessments for Chapter 4 Case Examples: Listing of Case Diagnoses. Case Review for Myrna Joy Bilbus. Case Review for Mary James. 5 The Substance-Related Disorders. Introduction. Incidence and Prevalence. Overview of the Major Characteristics of the Diagnostic Classifications. Adding Diagnostic Specificity. Looking at the Specific Substances. Final Thoughts. Practicing the Competency-Based Assessment. Practical Applications. Appendix: Competency-Based Assessments for Chapter 5 Case Examples: Listing of Case Diagnoses. Case Rewiew for Georgette Turnbull. Case Review for Frankie Singer. 6 Schizophrenia and Other Psychotic Disorders. Introduction. Incidence and Prevalence. Overview of Major Symptoms. The Path of Schizophrenia. Paranoid-Type Schizophrenia. Disorganized-Type Schizophrenia. Catatonic-Type Schizophrenia. Undifferentiated-Type Schizophrenia. Residual-Type Schizophrenia. The Other Psychotic Disorders. Final Thoughts. Practicing the Competency-Based Assessment. Practical Applications. Appendix: Competency-Based Assessments for Chapter 6 Case Examples: Listing of Case Diagnoses. Case Review for John Potter. Case Review for Hubert Estevez. 7 The Mood Disorders. Introduction. Incidence and Prevalence. Building Blocks for the Mood Disorders. The Depressive Disorders. The Bipolar Disorders. The Other Mood Disorders. Final Thoughts. Practicing the Competency-Based Assessment. Practical Applications. Appendix: Competency-Based Assessments for Chapter 7 Case Examples: Listing of Case Diagnoses. Case Review for L.C. Jones. Case Review for Marilyn Greene. 8 Anxiety Disorders. Introduction. Incidence and Prevalence. Overview of the Major Characteristics of the Diagnostic Classifications. Generalized Anxiety Disorder. Panic Disorder. The Phobias. Obsessive-Compulsive Disorder. Posttraumatic Stress Disorder. Final Thoughts. Practicing the Competency-Based Assessment. Practical Applications. Appendix: Competency-Based Assessments for Chapter 8 Case Examples: Listing of Case Diagnoses. Case Review for Marybeth Mc Kenna. Case Review Tom Donohue. 9 Somatoform, Factitious and Malingering Disorders. Introduction. Incidence and Prevalence. Overview of the Major Characteristics of the Diagnostic Classifications. Somatization Disorder. Conversion Disorder. Pain Disorder. Hypochondriasis. Body Dysmorphic Disorder. Somatoform Disorder Not Otherwise Specified (NOS). Related Disorders Causing Somatic Complaints: Malingering and Factitious Disorder. Final Thoughts. Practicing the Competency-based Assessment. Practical Applications. Appendix: Competency-Based Assessments for Chapter 9 Case Examples: Listing of Case Diagnoses. Case Review for James LaDuke. Case Review for June Dwyer. 10 The Dissociative Disorders. Introduction. Incidence and Prevalence. Overview of the Major Characteristics of the Dissociative Disorders. The Dissociative Disorders. Final Thoughts. Practicing the Competency-Based Assessment. Practical Applications. Appendix: Competency-Based Assessments for Chapter 10 Case Examples: Listing of Case Diagnoses. Case Review for Christopher Columbo. Case Review for Illeana Rodriquez. 11 Eating Disorders. Introduction. Incidence and Prevalence. Overview of Major Symptoms. Anorexia Nervosa. Bulimia Nervosa. Binge-Eating Disorder. Final Thoughts. Practicing the Competency-based Assessment. Practical Applications. Appendix: Competency-Based Assessments for Chapter 11 Case Examples: Listing of Case Diagnoses. Case Review for Nell Jordan. Case Review for Caroline Walker. 12 The Personality Disorders. Introduction. Incidence and Prevalence. Overview of the Major Characteristics of the Personality Disorders. The Cluster A Disorders—Odd and Eccentric. The Cluster B Disorders—Emotional, Dramatic or Erratic. The Cluster C Disorders—Anxious, Fearful. Final Thoughts. Practicing the Competency-Based Assessment. Practical Applications. Appendix: Competency-Based Assessments for Chapter 12 Case Examples: Listing of Case Diagnoses. Case Review for Melvin Myers. Case Review for Denise McMinville. References. Author Index. Subject Index.

Read more less

Book SynopsisSoft tissue tumors (STTs) are frequently misdiagnosed in inexperienced hands. Having diagnosed and treated hundreds of patients with these difficult tumors in the last few years, Institut Curie physicians have collected core data contributing to breakthrough research into the morphological, biological, and molecular aspects of soft tissue tumors, resulting in valuable translational and clinical applications to patient treatment. Soft Tissue Tumors: A Multidisciplinary, Decisional Diagnostic Approach presents a distillation of these experiences, combined with valuable data and perspectives contributed by senior pathologists, oncologists, and radiologists from several of the world's other leading cancer centers of excellence.Trade Review Table of ContentsForeword (Alain Verhest). Preface. Acknowledgments. Contributors. 1 Clinical approach in soft tissue tumors (Francois Goldwasser). 1.1 Epidemiology. 1.2 Clinics and clinical profiles. 1.3 Clinical differential diagnosis. 1.4 The importance of molecular diagnosis and its perspectives. 1.5 Treatment strategies. 2 Radiological diagnostic approach in soft tissue tumors (Hervé Brisse). 2.1 Introduction. 2.2 Patient management. 2.3 Imaging techniques. 2.4 Radiologic characterization. 2.5 Tumor biopsy. 3 Sampling procedure, fine needle aspiration (FNA), and core needle biopsy (CNB) (Henryk A. Domański). 3.1 Advantages and limitations of FNA and CNB in soft tissue lesions. 3.2 Techniques of FNA and CNB as applied to soft tissue lesions. 3.3 Processing the FNA and CNB samples and preparation of the FNA specimen for ancillary techniques. 3.4 Challenges in the FNA and CNB of soft tissue. 3.5 Complications of FNA and CNB of soft tissue. 4 Ancillary techniques. 4.1 Immunocytochemistry (Carlos Bedrossian). 4.2 Immunohistochemistry (Réal Lagacé). 4.3 Genetic Techniques (Jérôme Couturier). 4.4 Grading of soft tissue tumors (Réal Lagacé). 4.5 Future investigations of ancillary techniques (Stamatios Theocharis). 5 Principal aspects in fine needle aspiration and core needle biopsies (Jerzy Klijanienko and Réal Lagacé). 5.1 Normal tissue. 5.2 Cytologic classification of soft tissue tumors based on the principal patterns. 5.3 Diagnostic accuracy of FNA in soft tissue tumors. 5.4 Smear composition and the differential diagnosis of soft tissue tumors. 6 Particular aspects (Jerzy Klijanienko and Réal Lagacé). 6.1 Low-grade spindle cell tumors. 6.1.1 Fibromatoses and Desmoids. 6.1.2 Nodular Fasciitis. 6.1.3 Dermatofibrosarcoma Protuberans. 6.1.4 Benign Fibrous Histiocytoma (Cellular and Atypical Variants). 6.1.5 Solitary Fibrous Tumor. 6.2 Tumors with fibrillary stroma. 6.2.1 Benign Peripheral Nerve Sheath Tumors (Schwannoma, Ancient Schwannoma and Neurofibroma). 6.2.2 Low-Grade Malignant Peripheral Nerve Sheath Tumor. 6.3 Malignant spindle cell tumors. 6.3.1 Leiomyosarcoma. 6.3.2 Synovial Sarcoma. 6.3.3 Fibrosarcoma. 6.3.4 Malignant Fibrous Histiocytoma Storiform Pattern. 6.3.5 Malignant Peripheral Nerve Sheath Tumor. 6.3.6 Spindle Cell Angiosarcoma. 6.3.7 Kaposi Sarcoma. 6.4 Myxoid tumors. 6.4.1 Myxoid Liposarcoma (With or Without Round or Spindle Cells). 6.4.2 Myxofibrosarcoma. 6.4.3 Myxoid Leiomyosarcoma. 6.4.4 Myxoma and Cellular Myxoma. 6.4.5 Chordoma. 6.4.6 Extraskeletal Myxoid Chondrosarcoma. 6.5 Atypical lipomatous tumors. 6.5.1 Well-Differentiated liposarcoma / Atypical Lipoma. 6.5.2 Spindle Cell and Pleomorphic Lipoma. 6.6 Epithelioid tumors. 6.6.1 Epithelioid Sarcoma. 6.6.2 Gastrointestinal Stromal Tumor (GIST)/Epithelioid Leiomyosarcoma. 6.6.3 Epithelioid Angiosarcoma. 6.6.4 Granular Cell Tumor. 6.6.5 Rhabdoid Tumor. 6.6.6 Alveolar Soft Part Sarcoma. 6.6.7 Clear Cell Sarcoma. 6.6.8 Malignant Melanoma and Metastases. 6.7 Pleomorphic sarcomas. 6.7.1 Pleomorphic Malignant Fibrous Histiocytoma. 6.7.2 Pleomorphic Liposarcoma. 6.7.3 Pleomorphic Leiomyosarcoma and Rhabdomyosarcoma. 6.7.4 Extraskeletal Osteosarcoma. 6.7.5 Pleomorphic Malignant Peripheral Nerve Sheath Tumor. 6.8 Round cell sarcomas. 6.8.1 Embryonnal and Alveolar Rhabdomyosarcoma. 6.8.2 Ewing Sarcoma/Peripheral Neuroectodermal Tumor. 6.8.3 Desmoplastic Small Round Cell Tumor. 6.8.4 Extraskeletal Mesenchymal Chondrosarcoma. 6.8.5 Poorly Differentiated Synovial Sarcoma. Index.

Read more less

Book SynopsisDiagnosing Autism Spectrum Disorders The past decade has seen a tremendous increase in the number of people being diagnosed with Autism Spectrum Disorders and not just young children. Diagnosing Autism Spectrum Disorders: A Lifespan Perspective is the first volume of its kind to provide authoritative information for professionals on how to appropriately evaluate and diagnose these disorders in individuals of all ages. Donald P. Gallo, a board-certified clinical psychologist, shares his professional insights and expertise garnered from more than 1,500 autism evaluations over the past ten years. The book includes in-depth interviewing strategies that focus on the three primary areas of impairment socialization, communication, and behavior to determine if an individual has an Autism Spectrum Disorder. Differential diagnostic considerations are also addressed, and numerous case examples provide further clarity. Ways to present the assessment findings to parents Table of ContentsPreface ix Acknowledgments xiii About the Author xv 1. A Brief Look at the History of Autism 1 2. The Importance of the Autism Referral 5 3. How to Conduct the Evaluation 17 4. Information to Gather at the Outset of the Evaluation 33 5. Diagnostic Criteria for the Autism Spectrum Disorders 39 6. The Main Problem Areas of Autism: Social Impairment 45 7. The Main Problem Areas of Autism: Language Impairment 61 8. The Main Problem Areas of Autism: Behavioral Concerns 79 9. Additional Questions to be Asked when Interviewing Teens 87 10. Additional Questions to be Asked when Interviewing Adults 97 11. Other Important Factors to Take into Consideration 105 12. Differential Diagnosis through the Lifespan 117 13. Feedback for the Patient and Family/Parents 143 Appendix A: Sample Copy of My Questionnaire 151 Appendix B: Sample Copies of Reports 157 References 179 Index 181

Read more less

Book SynopsisFLOW CYTOMETRY PRINCIPLES FOR CLINICAL LABORATORY PRACTICE Quality Assurance for Quantitative Immunophenotyping Marilyn A. Owens and Michael R. Loken Flow Cytometry Principles for Clinical Laboratory Practice is aninvaluable benchtop reference and introduction for first-time usersof flow cytometry in clinical diagnostic laboratories. This manualprovides authoritative coverage of accepted methods, qualitycontrols, and standards for the cytometric analysis of clinicalsamples with particular relevance to CD4+ lymphocytes. CD4+lymphocyte determination by immunophenotyping is the standardmethod for evaluating the status of HIV infection, and the singlemost frequent application of flow cytometry in a diagnosticsetting. Flow Cytometry Principles for Clinical Laboratory Practice willappeal to clinical laboratory technologists, medical practitioners,and cytometry lab directors in their role as instructors of newpersonnel. In addition, it is a valuable resourcTable of ContentsAssumptions in Flow Cytometry. Components of Flow Cytometric Immunophenotyping. Quality Control of Flow Cytometer and Reagents. Quantitative Immunophenotyping in HIV Infection. Peripheral Blood Stem Cell Quantitation. Variability in Immunophenotyping. Safety and Specimen Acquisition, Handling, and Processing. Analysis of FCI Results and Troubleshooting. New Methods for Cell Enumeration. Index.

Read more less

Book SynopsisThis book summarizes the results of studies on charge transfer photochemistry of metal complexes of the past few years.Table of ContentsPhotochemical Laws/ Photochemistry and Photophysics/ Spectra and Photochemistry of Coordination Compounds/ Photoredox Properties of Metal Complexes: Copper, Silver, and Gold - Magnesium, Zinc, Cadmium, and Mercury - Aluminum, Gallium, Indium, Thallium, Yttrium, Lanthanides, and Actinides - Silicon, Germanium, Tin, Lead, and Titanium - Antimony, Bismuth, Vanadium, Niobium, and Tantalum - Tellurium, Chromium, Molybdenum, and Tungsten - Manganese, Technetium, and Rhenium, Iron Ruthenium and Osmium - Nickel, Palladium, and Platinum, Cobalt, Rhodium and Iridium

Read more less

Book SynopsisNew Directions in Interpreting the Millon Clinical Multiaxial Inventory, edited by a leading MCMI researcher and featuring contributions from internationally renowned scholars in personality assessment, presents new methods of interpretation and new clinical applications for this classic objective measure of personality. This dynamic new handbook discusses issues related to the effect of culture on MCMI-III results and controversies regarding its forensic applications, and presents research related to the MCMI-III''s diagnostic power with regard to diagnosis and malingering.Table of ContentsContributors. Introduction. Part I: New Directions in MCMI Interpretation. 1. The MCMI-III Facet Subscales (Seth D. Grossman and Cristian del Rio). 2. Diagnosing Personality Disorder Subtypes with the MCMI-III (Roger D. Davis and Michael J. Patterson). 3. Alternative Interpretations for the Histrionic, Narcissistic, and Compulsive Personality Disorder Scales of the MCMI-III (Robert J. Craig). 4. Combined Use of the PACL and MCMI-III to Assess Normal Range Personality Styles (Stephen Strack). 5. Issues in the Assessment of Personality Disorders and Substance Abusers with the MCMI (Patrick M. Flynn). 6. International Uses of the MCMI: Does Interpretation Change? (Gina Rossi and Hedwig Sloore). Part II: Newer Applications with the MCMI-III. 7. Using the MCMI-III for Treatment Planning and to Enhance Clinical Efficacy (Jeffrey J. Magnavita). 8. Use of the MCMI-III with Other Personality Inventories (Robert J. Craig). 9. Forensic Application of the MCMI-III in Light of Current Controversies (Frank J. Dyer). Part III: Continuing Controversies. 10. Assessing Response Bias with the MCMI Modifying Indices (R. Michael Bagby and Margarita B. Marshall). 11. Validity of the MCMI-III in the Description and Diagnosis of Psychopathology (Andrew G. Ryder and Scott Wetzler). 12. The Diagnostic Efficiency of the MCMI-III in the Detection of Axis I Disorders (Paul Gibeau and James Choca). 13. On the Decline of MCMI-Based Research (Robert J. Craig and Ronald E. Olson). 14. Using Critiques of the MCMI to Improve MCMI Research and Interpretations (Louis Hsu). Appendix A: Diagnoses Associated with MCMI Code Types. Appendix B: Millon Clinical Multiaxial Inventory Bibliography. About the Editor. Author Index. Subject Index.

Read more less

Book SynopsisReviews the biochemical and physiological abnormalities in each of the body''s organ systems, enabling investigators to decide if the problem is of drug-induced origin. Much of the material is presented as a series of observations with accompanying questions which should be addressed in order to make an accurate diagnosis. Includes useful flow charts for the management of adverse drug events and examples of specific report forms.Table of ContentsPartial table of contents: DIAGNOSIS AND MANAGEMENT OF ADVERSE DRUG REACTIONS. Liver Test Abnormalities (G. Danan). Abnormal Hematologic Values (P. Solal-Celigny). Acute Renal Failure (E. Rothschild). Respiratory Disorders (M. Fournier). Neurological and Muscular Disorders. Abnormal Blood Pressure. Cardiac Disorders. Psychiatric Disorders (C. Peretti). Adverse Drug Reactions in HIV-Seropositive Patients (C. Benichou,et al.). REGULATORY AND TECHNICAL ISSUES. International Reporting Requirements for Adverse Drug Events (E.Weidmann). Harmonization of International Reporting of Safety Information forMarketed Drugs: The Proposals of the CIOMS Working Groups I and II(C. Benichou). A New Method for Causality Assessment: RUCAM (C. Benichou G.Danan). Appendix. Index.

Read more less

Book SynopsisImmunoassays are in use in many laboratories and across many disciplines. They involve the use of antibodies to detect and quantitate proteins. The Essential Data Series is a series of handy pocket-sized books which allow researchers to have all the key experimental facts at their fingertips.Table of ContentsHistory and Classification (R. Edwards). Antibodies and Antisera (R. Edwards). Assay Design (R. Edwards). Seperation (R. Edwards). Radiolabeled Immunoassays (R. Edwards). Enzyme-labeled Immunoassay (J. Little). Flurescent and Phosphorescent Labeled Assays (S. Blincko). Chemiluminescent and Bioluminescent Labeled Assays (S. Blincko). Precipitation and Agglutination Methods (J. Little). Dry Surface Immunoassays and Immunosensors (R. Edwards). Data Processing (I. Howes). Manufacturers and Suppliers. References. Index.

Read more less

Book SynopsisThis revision and reference text for pre-registration and postgraduate optometrists covers procedures for investigating heterophoria, heterotropia, vergence and accommodative anomalies, and the diagnosis of disorders of voluntary eye movement, nystagmus and supranuclear defects, paresis and non-paralytic incomitancy. Both motor and sensory anomalies are discussed together with syndromes involving oculomotor anomalies. Clinical management is outlined in protocols in an easily assimilable form. The new edition includes two new chapters on vision training and case management which will interest optometrists and orthoptists involved in sports vision, developmental vision therapy and the care of ophthalmic patients with neurological lesions. Pre-registration optometrists will find the chapters on routine orthoptic assessment and the professional qualifying examination of particular interest.Table of ContentsNormal and abnormal binocular vision;. Background: orthoptic terminology, surgical principles, the development of orthoptic techniques;. Ocular deviations: motor anomalies;. Ocular adaptations: sensory anomalies;. Clinical investigation of binocular anomalies;. Heterophoria and anomalies of vergence and accommodation;. Exercises for vergence, version and fixation;. Heterotropia;. Incomitancy;. Nystagmus, irregular eye movements, internuclear and supranuclear binocular anomalies;. Professional qualifying examination technique;. Case studies;. References and background reading;. Appendices;. Index. Differential diagnosis of strabismus and amblyopia;. History of orthoptic;. Oculomotor deviations;. Oculosensory anomalies;. Routine orthoptic procedures;. Heterophoria assessment and management protocols;. Vision training exercises;. Concomitant heterotropia classification, diagnosis and treatment;. Acute strabismus, supranuclear eye movement disorders, nystagmus, strabismus syndromes;. Professional examination technique and questions;. Case management examples;. Glossary

Read more less

Book SynopsisThere are many problems in working psychotherapeutically across cultures, with numerous examples of failure to understand cultural issues. For example, the ignorance of traditional family structures can lead to major diagnostic and therapeutic errors.Table of ContentsContributors. Preface to First Edition. Preface to Second Edition. Part I: Themes. 1. Towards an Intercultural therapy. 2. The Nafsiyat Intercultural Therapy Centre: Ideas and Experience in Intercultural Therapy. 3. How universal Is Something We Can Call "Therapy". Part II: Interpretations. 4. Interprofessional Consultation: Consultative Approaches in Therapeutic Work Across Cultures. 5. The Doctors Dilemma: The Practice of Cultural Psychiatry in Multicultural Britain. 6. Quantitative Research in Intercultural Therapy: Some Methodological Considerations. Part III: Practice. 7. The Bradford Experience. 8. Familiar and Unfamiliar Types of Family Structure: Towards a Conceptual Framework. 9. Racism and Psychotherapy; Working with Racism in the Consulting Room; an Analytical View. 10. Inner and Outer Reality in Children and Adolescents. 11. Intercultural Social Work. 12. Therapeutic Approaches with Survivors of Torture. Appendix. References and Further Reading. Index.

Read more less

Book SynopsisSports concussions make headlines, but you don't have to be an NFL star to suffer traumatic brain injury. In Shaken Brain, Elizabeth Sandel, MD, shares stories and research from her decades treating and studying brain injuries. She explains what concussions do to our bodies, how to avoid them, and how to recover.Trade ReviewA fascinating page turner. Propelled by Dr. Sandel’s exceptional storytelling and clinical expertise, Shaken Brain sheds light on the myths and misunderstandings surrounding concussions, and their consequential impact on so many lives. -- Marilyn Spivack, cofounder and past President, Brain Injury Association of AmericaA thoroughly engaging and enlightening account, this book explores the often perplexing issues and controversies surrounding post-concussion symptoms. A vital read. -- Mel Glenn, MD, Spaulding Rehabilitation NetworkI was a doctor in 2002 when I suffered a traumatic brain injury. Even in my position, it was difficult to find information about post-concussive consequences and care. Shaken Brain fills in the gaps. Uniting clinical research, scientific data, and personal stories, this crucial resource is one that both physicians and their patients can look to for answers. -- Cheryle Sullivan, MD, author of Brain Injury Survival KitThe first step to improving concussion care is improving concussion education. Whether you’re an athlete, a parent, a medical professional, or none of the above, having the proper knowledge about what a concussion is and what to do when one is sustained can often be the difference between a quick recovery and a lengthy one. A book like Shaken Brain offers needed information. -- Brittni Souder, former soccer player and Board Member, PINK ConcussionsShaken Brain is frank, accessible, and authoritative—a crucial tool for sharing medical knowledge. Read this book if you are a traumatic brain injury survivor, a clinician, a family member, or simply interested in learning more about brain health. -- David Cifu, MD, Virginia Commonwealth University School of Medicine and the US Department of Veterans AffairsA physician with over 25 years’ experience studying and treating concussion details what happens in the human brain when it is injured, and how medical providers can help…Emphasizing that it isn’t just athletes who need to worry, Sandel examines the high incidence of concussion among certain vulnerable populations, including the very young, elderly, homeless or impoverished, and victims of child abuse or domestic violence. To that end, she looks at prevention as a public health issue…Her expertly presented and researched work will be invaluable for anyone concerned about concussions. * Publishers Weekly *I recommend Shaken Brain to anyone interested in a deeper, nuanced understanding of concussion/mild TBI. Dr. Sandel effortlessly conveys the information typically found in a textbook with the ease and style of a novelist. It is a valuable resource for patients who have experienced concussion and their families, as well as for the physicians, therapists, and scientists who have made it their life’s work to help them. -- John Leddy * Brain Injury *

Read more less

Book SynopsisThis unique care plan text is packed with outstanding features - it's the resource students will turn to again and again. They'll find everything they need to create and implement great care plans across the lifespan.Table of Contents Introduction Health Perception-Health Management Pattern Nutritional-Metabolic Pattern Elimination Pattern Activity-Exercise Pattern Sleep-Rest Pattern Cognitive-Perceptual Pattern Self-Perception and Self-Concept Pattern Role-Relationship Pattern Sexuality-Reproductive Pattern Coping-Stress Tolerance Pattern Value-Belief Pattern Appendix A: NANDA's Axes DefinitionsAppendix B: Admission Assessment Form and Sample

Read more less

Book SynopsisPresents up-to-date coverage of routine procedures and their complications as well specialized procedures, quality and infection control, state-of-the-art equipment, medical terminology, ethical and legal issues, body systems, and related diagnostic laboratory tests. Videos, animations, and review questions online help you to excel.Table of Contents PART ONE PHLEBOTOMY AND THE HEALTHCARE FIELD 1. Phlebotomy and the Healthcare Delivery System 2. The Clinical Laboratory 3. Safety and Infection Control PART TWO BODY SYSTEMS 4. Basic Medical Terminology 5. Basic Anatomy and Physiology 6. The Circulatory System PART THREE PHLEBOTOMY TECHNIQUES 7. Venipuncture Equipment 8. Routine Venipuncture 9. Pre-examination Variables and Venipuncture Complications 10. Special Blood Collection 11. Dermal Puncture 12. Arterial Blood Collection PART FOUR ADDITIONAL TECHNIQUES 13. Point-of-Care Testing 14. Additional Duties of the Phlebotomist PART FIVE QUALITY PHLEBOTOMY 15. Ethical and Legal Issues 16. Quality Management in Phlebotomy APPENDIX A: Common Laboratory Tests and the Collection Tube Requirements APPENDIX B: Answers to Study Questions APPENDIX C: Answers to Clinical Situations APPENDIX D: Abbreviations APPENDIX E: English-Spanish Phrases for Phlebotomy GLOSSARY INDEX

Read more less

Book SynopsisDescribes various known common ECG abnormalities and cardiac arrhythmias with a practical and clinical approach. This book explains each abnormality, including definition, diagnostic criteria, and diagnostic pearls. It shows reproduction of a given ECG abnormality. It is useful for interpretation of ECGs.Table of ContentsPreface to the Second Edition. Preface to the First Edition. Abbreviations. Suggested Readings. 1. Introduction. 2. Normal Electrocardiogram and Normal Variants. 3. Chamber Enlargement. 4. Intraventricular Conduction Disturbances. 5. Myocardial Ischemia, Injury, and Infarction. 6. Diagnostic Approach to Cardiac Arrhythmias. 7. Disturbances of Sinus Impulse Formation and Conduction. 8. Atrial Arrhythmias. 9. Atrioventricular Junctional Arrhythmias. 10. Ventricular Arrhythmias. 11. Atrioventricular Block. 12. Wolff-Parkinson-White Syndrome (Ventricular pre-Excitation Syndrome). 13. Uncommon Arrhythmias and Electrocardiographic Abnormalities. 14. Artificial Pacemaker Rhythms. 15. Congenital Heart Disease. 16. Electrolyte Imbalances. 17. Miscellaneous Electrocardiographic Findings. Index.

Read more less

Book SynopsisAs teachers of neurology to postgraduates, the authors found that most students had a good general idea of the parts of a neurological examination but were unclear about many other specifics. These included, among others, the best methods of carrying out the various tests; the purpose of each test; how to overcome technical difficulties; the true meaning of abnormal findings; and how to avoid arriving at false conclusions. This book details methods that have stood the test of time and additionally outlines some newer methods that are are already proving their value. In no sense is this book either a textbook of neurology or a guide to neurological diagnosis. It does, however, aim to help the reader become sufficiently conversant with specific exam techniques to be able to approach neurological cases with much more confidence. In the sixth edition of this deservedly popular book, the general layout and structure of the chapters have been retained, a chapter on general medical investigatTrade Review"...this is an excellent book and one to be warmly recommended to those in neurological training." J. Neurology, Neurosurgery and Psychiatry on the Fifth Edition. "...a balanced and easily read account..." J. Royal College of Physicians on the Fifth Edition. "...a book of proved worth...Such good advice should be handed out to every newly qualified doctor and perhaps some already qualified." BMJ on the Fifth EditionTable of ContentsPart I: The Introductory Stages. Approaching a Neurological Problem. Equipment. The History. First Impressions. The General Physical and Mental Examination. Part II: The Cranial Nerves. The First Cranial Nerve: The Olfactory Nerve. The Second Cranial Nerve: The Optic Nerve. The Third, Fourth and Sixth Cranial Nerves: The Oculomotor, Trochlear and Abducent Nerves. The Fifth Cranial Nerve: The Trigeminal Nerve. The Seventh Cranial Nerve: The Facial Nerve. The Eighth Cranial Nerve: The Auditory Nerve. The Ninth and Tenth Cranical Nerves: The Glossopharyngeal and Vagus Nerves. The Eleventh Cranial Nerve: The Accessory Nerve. The Twelfth Cranial Nerve: The Hypoglossal Nerve. Part III: The Motor System. Development and Wasting. Muscle Tone. Muscle Power. Posture, Stance, Spinal Movement and Gait. Involuntary Movements. Part IV: The Sensory System. Basic Principles for Examination of Sensation. Pain, Touch and Temperature. The Proprioceptive Sensations. Stereognosis, Discriminative Sense and Graphaesthesia. Common Patterns of Abdormal Sensation. Part V: The Motor-Sensory Links. The Reflexes. Co-ordination. Part VI: Examinations of Particular Difficulty. The Unconscious Patient. Disorders of Speech. Apraxia. Agnosia and Disorders of the Body Image. The Autonomic Nervous System. Part VII: The Investigation of Neurological Problems. Towards A Balanced Attitude. General Medical Investigation. The Cerebrospinal Fluid. Neuroradiology and Imaging. The Clinical Value of Electroencephalography. Peripheral Electrophysiology. Biopsy. Part VIII: Appendices. Recording the Neurological Examination. First Examination in the Out-Patient Department or Consulting Room. A Suggested Scheme for the Examination of Higher Cerebral Function. Index.

Read more less

Book SynopsisIntroduces the knowledge and skills needed to analyze symptoms, physical findings, and ECG and x-ray abnormalities in order to accurately diagnose more than 50 different conditions that may bring about a complaint of 'chest pain'. This book concentrates on causative syndromes or maladies, from its initial presentation to its etiology.Trade Review"This book...is worth owning. It is not going out of date next year!" William C. Roberts American Journal of CardiologyTable of ContentsPreface. Chapter 1. An Explanation of the Title and General Comments. J. Willis Hurst, M.D. PART I: Skin Disease as a Cause for "Chest Pain". Chapter 2. "Chest Pain" in Patients with Herpes Zoster (Shingles). Calvin O. McCall, M.D. and S. Wright Caughman, M.D.. PART II: Musculoskeletal Diseases as a Cause for "Chest Pain". Chapter 3. "Chest Pain" in Patients with Costochondritis or Tietze's Syndrome. Byron R. Williams, M.D.. Chapter 4. "Chest Pain" in Patients with Thoracic Outlet Syndromes. Vinod H. Thourani, M.D. and Joseph I. Miller, Jr., M.D.. Chapter 5. "Chest Pain" in Patients with Chest Wall Syndromes. J. Willis Hurst, M.D. Chapter 6. "Chest Pain" in Patients with the Shoulder-Hand Syndrome. Mark E. Silverman, M.D.. Chapter 7. "Chest Pain" in Patients with Bursitis of the Shoulder. Stephen B. Miller, M.D. Chapter 8. "Chest Pain" in Patients with Rotator Cuff Tendonitis or Arthritis of the Shoulder. Andrew P. Gutow, M.D. Chapter 9. "Chest Pain" in Patients with Joint Disease of the Cervical or Thoracic Spine. Stephen B. Miller, M.D.. PART III: Thrombophlebitis as a Cause for "Chest Pain". Chapter 10. "Chest Pain" in Patients with Mondor's Syndrome. Stephen D. Clements, Jr., M.D.. PART IV: Neurologic Disease as a Cause for "Chest Pain". Chapter 11. "Chest Pain" in Patients with Cervical Disc Syndromes. David J. Hewitt, M.D. Chapter 12. "Chest Pain" in Patients with Brachial Plexus Neuropathy. David J. Hewitt, M.D. PART V: Mediastinal Disease as a Cause for "Chest Pain". Chapter 13. "Chest Pain" in Patients with Mediastinal Emphysema. Talmadge E. King, Jr., M.D. PART VI: Pulmonary Causes of "Chest Pain". Chapter 14. "Chest Pain" in Patients with Pleuritis. Talmadge E. King, Jr., M.D.. Chapter 15. "Chest Pain" in Patients with Pneumothorax. Talmadge E. King, Jr., M.D.. Chapter 16. "Chest Pain" in Patients with Pulmonary Embolism. Nanette K. Wenger, M.D. Chapter 17. "Chest Pain" in Patients with "Café" Coronary. Stephen D. Clements, Jr., M.D. PART VII: Diseases of the Gastrointestinal Tract as a Cause for "Chest Pain". Chapter 18. "Chest Pain" in Patients with Esophageal Motility Disorders. J. Patrick Waring, M.D. Chapter 19. "Chest Pain" in Patients with Gastroesophageal Reflux. J. Patrick Waring, M.D. Chapter 20. "Chest Pain" in Patients with Esophageal Rupture. J. Patrick Waring, M.D. Chapter 21. "Chest Pain" in Patients with Esophageal Stenosis. J. Patrick Waring, M.D. Chapter 22. "Chest Pain" in Patients with Pill-Induced Esophagitis. J. Patrick Waring, M.D. Chapter 23. "Chest Pain" of Esophageal Origin in Patients with HIV. J. Patrick Waring, M.D.. Chapter 24. "Chest Pain" in Patients with Peptic Ulcer Disease. Steve Goldschmid, M.D. PART VIII: Diseases of the Gallbladder and Biliary Tract as Causes of "Chest Pain". Chapter 25. "Chest Pain" in Patients with Biliary Colic. Steve Goldschmid, M.D. Chapter 26. "Chest Pain" in Patients with Acute Cholecystitis. Steve Goldschmid, M.D. PART IX: Pericardial Disease as a Cause for "Chest Pain". Chapter 27. "Chest Pain" in Patients with Acute Pericarditis. David H. Spodick, MD, DSc. PART X: Heart Disease as a Cause for "Chest Pain". Chapter 28. "Chest Pain" in Patients with Cardiac Arrhythmias. Paul F. Walter, M.D. and J. Willis Hurst, M.D.. Chapter 29. "Chest Pain" in Patients with Angina Pectoris. J. Willis Hurst, M.D. Chapter 30. "Chest Pain" in Patients with Myocardial Infarction. Douglas C. Morris, M.D. Chapter 31. "Chest Pain" in Patients with Prinzmetal''s Angina. David Waters, M.D. and Rabih R. Azar, M.D., M.Sc. Chapter 32. "Chest Pain" in Patients with Myocardial Infarction with Normal or Near Normal Coronary Arteriogram. Rabih R. Azar, M.D., M.Sc. and David Waters, M.D.. Chapter 33. "Chest Pain" in Patients Who Use Cocaine. Jessica Haberer, M.D. and David Waters, M.D.. Chapter 34. "Chest Pain" in Patients with Congenital Heart Disease. Joseph K. Perloff, M.D.. Chapter 35. "Chest Pain" in Patients with Aortic Valve Stenosis. Douglas C. Morris, M.D. Chapter 36. "Chest Pain" in Patients with Aortic Valve Regurgitation. Douglas C. Morris, M.D. Chapter 37. "Chest Pain" in Patients with Rheumatic Mitral Valve Stenosis. Douglas C. Morris, M.D. Chapter 38. "Chest Pain" in Patients with Hypertrophic Cardiomyopathy. Douglas C. Morris, M.D.. Chapter 39. "Chest Pain" in Patients with Dilated Cardiomyopathy. Douglas C. Morris, M.D. Chapter 40. "Chest Pain" in Patients with Restrictive Cardiomyopathy. Douglas C. Morris, M.D. Chapter 41. "Chest Pain" in Patients with Pulmonary Hypertension. Robert C. Schlant, M.D. Chapter 42. "Chest Pain" in Patients with Systemic Hypertension. J. Willis Hurst, M.D. PART XI: "Chest Pain" Caused by Diseases of the Aorta. Chapter 43. "Chest Pain" in Patients with Aortic Dissection. Joseph Lindsay, Jr., M.D. Chapter 44. "Chest Pain" in Patients with Aortic Aneurysms. Joseph Lindsay, Jr., M.D. PART XII: "Chest Pain" Related to Emotional or Psychiatric Conditions. Chapter 45. "Chest Pain" in Patients with Anxiety Disorders. Bernard L. Frankel, M.D.. Chapter 46. "Chest Pain" in Patients with Depressive Disorders. Bernard L. Frankel, M.D.. Chapter 47. "Chest Pain" in Patients Who Are Malingering. James C. Hamilton, Ph.D. and Marc D. Feldman, M.D.. Chapter 48. "Chest Pain" in Patients with Factitious Disorder Including Munchausen Syndrome. Marc D. Feldman, M.D. and James C. Hamilton, Ph.D.. Chapter 49. "Chest Pain" in Patients with Addiction. Karen Drexler, M.D.. PART XIII: "Chest Pain" of Controversial Origin. Chapter 50. "Chest Pain" in Patients with Syndrome X. Richard O. Cannon III, M.D.. Chapter 51. "Chest Pain" in Patients with Mitral Valve Prolapse. J. Willis Hurst, M.D.. PART XIV: Final Comments. Chapter 52. The Evolution of our Knowledge and Remaining Problems. J. Willis Hurst, M.D.

Read more less

Book SynopsisThis volume explores the latest technological advances and covers all facets of systems medicine with respect to precision medicine. The chapters in this book are organized into four parts. Part One highlights the recent achievements in proteomics for biomarkers identification, integration of omics and phenotypic data for precision medicine, and medicine-guided treatment of drug-induced Stevens-Johnson syndrome. Part Two covers systems-based computational approaches for pharmaceutical research and drug development, the principle of optimizing systemic exposure of drugs, and Animal Rule for drug repurposing. Part Three looks at computational tools and methodologies of network biology, quantitative systems toxicology, and modeling and stimulating patient response variabilities. Part Four talks about how systems medicine can address unmet medical and health needs, and identify educational needs. Written in the highly successful Methods in Molecular Biology series format, chapters include Table of ContentsAcknowledgements…Preface…Table of Contents…Contributing Authors…Part I Scientific and Medical Advances1. Mass Spectrometry-Based Proteomics for Biomarker DiscoveryZhijun Cao and Li-Rong Yu2. Integration of Omics and Phenotypic Data for Precision MedicineJuan Zhao, QiPing Feng, and Wei-Qi Wei3. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in the Era of Systems MedicineChun-Bing Chen, Chuang-Wei Wang, and Wen-Hung ChungPart II Acceleration of Pharmaceutical Research and Development4. Integration of Engineered Delivery with the Pharmacokinetics of Medical Candidates via Physiology-Based PharmacokineticsYuching Yang and Xinyuan Zhang5. Applications of Quantitative System Pharmacology Modeling to Model Informed Drug DevelopmentAndy Z.X. Zhu and Mark Rogge6. Combating Viral Diseases in the Era of Systems MedicineJane P.F. Bai and Ellen Y. Guo7. Toxicity Analysis of Pentachlorophenol Data with a Bioinformatics Tool SetNatalia Polouliakh, Takeshi Hase, Samik Ghosh, and Hiroaki KitanoPart III Tools and Methodologies8. Virtual Populations for Quantitative Systems Pharmacology ModelsYougan Cheng, Ronny Straube, Abed E. Alnaif, Lu Huang, Tarek A. Leil, and Brian J. Schmidt9. Quantitative Systems Toxicology and Drug Development: The DILIsym ExperiencePaul B. Watkins10. Introduction to Genomic Network Reconstruction for Cancer ResearchGuillermo de Anda Jáuregui, Hugo Tovar, Segio Alcalá-Corona, Enrique Hernández-Lemus11. Learning in Medicine: The Importance of Statistical ThinkingMassimiliano Russo and Bruno Scarpa12. Development and Applications of Interoperable Biomedical Ontologies for Integrative Data and Knowledge Representation and Multiscale Modeling in Systems MedicineYongqun HePart IV Systems Medicine to Address Unmet Medical Needs13. Systems Biology to Address Unmet Medical Needs in Neurological DisordersMasha G. Savelieff, Mohamed H. Noureldein, and Eva L. Feldman14. Informatics in Medical Product Regulation: The Right Drug at the Right Dose for the Right PatientEileen Navarro Almario, Anna Kettermann, and Vaishali Popat15. Personal Dense Dynamic Data Clouds Connect Systems Bio-Medicine to Scientific WellnessGilbert S. Omenn, Andrew T. Magis, Nathan D. Price, and Leroy Hood16. Educational Needs for Quantitative Systems Pharmacology ScientistsJames M. GalloSubject Index List…

Read more less

Book SynopsisFull exploitation of the DSM-5 allows for more comprehensive care By demystifying the DSM-5, author Sophia Dziegielewski goes beyond the traditional diagnostic assessment and suggests both treatment plans and practice strategy. She covers the changes in criteria to the DSM-5 and what those changes mean for mental health professionals. This resource has been updated to include: New and updated treatment plans All treatment plans, interventions strategies, applications, and practice implications are evidence based Instructions on doing diagnostic assessments and differential diagnosis using the DSM-5 Changes to coding and billing using the DSM-5 and ICD-10 The book includes robust tools for students, instructors, and new graduates seeking licensure. DSM-5 in Action makes the DSM-5 accessible to all practitioners, allowing for more accurate, comprehensive care.Trade Review"This book is a thoroughly researched and organized approach to understanding the DSM-5 and how to use its diagnostic criteria to create a treatment plan/practice strategy. It is easy to read and understand, and the case examples and treatment plans are well done." (Doody 2016)Table of ContentsPreface xiii Acknowledgments xvii Quick Reference List xix SECTION I Utilizing the DSM-5: Assessment, Planning, and Practice Strategy Chapter 1 Getting Started 3 Introduction 3 Beginning the Process 3 Making the Diagnostic Assessment: Tools That Facilitate the Assessment Process 4 Role of Social Workers and Other Mental Health Professionals 4 Development of the DSM Classification System: History and Reservations 6 Diagnostic Labels 14 Another Mental Health Assessment Measure 16 Professional Training in the Professional Counseling Fields 18 Summary 19 Questions for Further Thought 20 References 20 Chapter 2 Basics and Application 23 Utilizing the DSM-5 in the Practice Setting 23 Working as Part of a Team: Connections and Collaborations 25 Diagnosis and Assessment: Is There a Difference? 28 A Combination Approach: The Diagnostic Assessment 33 DSM-5 Updates and Structural Changes 35 DSM-5: Sections and Appendices 39 Important Sections in the DSM-5 45 Culture, Age, and Gender-Related Information 47 Concepts of Distress 53 Culture and Other Diagnostic Assessment Factors Related to Age 57 Culture and Other Diagnostic Assessment Factors Related to Gender 59 Summary 66 Questions for Further Thought 67 References 67 Chapter 3 Completing the Diagnostic Assessment 70 Basics for Completing a Comprehensive Diagnostic Assessment 70 DSM-5 and Completing the Diagnostic Assessment 74 The Principal Diagnosis 76 Subtypes and Course Specifiers 86 Ethical and Legal Considerations 101 Pulling It All Together 102 Summary 104 Questions for Further Thought 105 References 105 Chapter 4 Applications 107 Documentation, Treatment Planning, and Practice Strategy 107 Treatment and Intervention Planning 116 Developing the Treatment Plan 120 Selecting an Intervention Framework 123 Practice Strategy and Application 127 Types of Time-Limited Therapy in Mental Health Practice 131 Summary 140 Questions for Further Thought 143 References 143 SECTION II Diagnostic and Treatment Applications Chapter 5 Schizophrenia Spectrum and the Other Psychotic Disorders 149Sophia F. Dziegielewski Introduction 149 Toward a Basic Understanding of the Conditions 150 Understanding Individuals Who Suffer From the Psychotic Disorders 151 Important Features Related to the Psychotic Disorders 153 DSM-5: Assessment of Symptoms Measurement 157 Overview of Schizophrenia Spectrum and Other Psychotic Disorders 160 Schizophrenia 167 Beginning the Diagnostic Assessment 173 Schizophrenia and Factors for Consideration in the Diagnostic Assessment 174 Case Application of the Diagnostic Assessment 181 Treatment Planning and Intervention Strategy 186 Special Topics 195 Summary and Future Directions 196 References 197 Chapter 6 Bipolar and Related Disorders 202Sophia F. Dziegielewski and Olga Molina Introduction 202 Toward a Basic Understanding of the Bipolar and Related Disorders 202 Understanding Individuals Who Suffer From Bipolar and Related Disorders 204 Overview of the Bipolar and Related Disorders 212 Summary of Bipolar Disorders 221 Diagnostic Assessment in Adults With Bipolar Disorder 222 General Intervention Strategies: Models and Treatment Modalities for the Bipolar Disorders 232 Special Topics 236 Summary and Future Directions 238 References 239 Chapter 7 Depressive Disorders 242Sophia F. Dziegielewski Introduction 242 Toward a Basic Understanding of the Disorders 243 Important Features Related to the Depressive Disorders 244 Endogenous and Exogenous Depression: Making a Distinction 246 Overview of the Depressive Disorders 247 The Depressive Disorders and the Diagnostic Assessment 259 Special Topics 270 Assessment of Danger to Self or Others 271 Summary and Future Directions 272 References 273 Chapter 8 Obsessive-Compulsive and Related Disorders 278Sophia F. Dziegielewski and Barbara F. Turnage Introduction 278 Toward a Basic Understanding of the Obsessive-Compulsive and Related Disorders 278 Understanding Individuals Who Suffer From the OCD Spectrum Disorders: When Urges Become Overwhelming 280 Important Features Related to the Obsessive-Compulsive and Related Disorders 281 Overview of the Obsessive-Compulsive and Related Disorders 283 Toward a Better Understanding of Obsessive-Compulsive Disorder 289 Obsessive-Compulsive Disorders and the Factors for Consideration in the Diagnostic Assessment 291 Summary and Future Directions 306 References 306 Chapter 9 Trauma- and Stressor-Related Disorders 309Sophia F. Dziegielewski and Barbara F. Turnage Introduction 309 Toward a Basic Understanding of Trauma- and Stressor-Related Disorders 309 Understanding Individuals Who Suffer From the Trauma- and Stressor-Related Disorders 310 Important Features Related to the Trauma- and Stressor-Related Disorders 311 Overview of the Trauma- and Stressor-Related Disorders 313 Beginning the Diagnostic Assessment 321 Pulling It All Together: An Integrated Approach 333 Summary and Future Directions 335 References 335 Chapter 10 Sexual Dysfunctions 338Sophia F. Dziegielewski and Joshua Kirven Introduction 338 Toward a Basic Understanding of the Sexual Dysfunctions 338 Individuals Who Suffer From a Sexual Dysfunction 340 Important Features and Terms Related to the Sexual Dysfunctions 341 Overview of the Sexual Dysfunctions 343 Sexual Dysfunctions and the Diagnostic Assessment 353 Completing the Diagnostic Assessment 353 Overview of Treatment Methods for the Sexual Disorders 358 Selected Assessment Scales and Methods for Treating the Sexual Disorders 361 Special Topics 364 Applying a Cultural Competence Lens to Diagnosis 367 Summary and Future Directions 369 References 370 Chapter 11 Disruptive Impulse-Control and Conduct Disorders 375Sophia F. Dziegielewski and Ana M. Leon Introduction 375 Living With Problematic Self-Control of Emotions and Behavior 376 Overview of the Disruptive, Impulse-Control, and Conduct Disorders 377 The Diagnostic Assessment: Application Basics 387 General Intervention Strategies: Models and Treatment Modalities 403 Summary and Future Directions 411 References 412 Chapter 12 Substance-Related and Addictive Disorders 417Sophia F. Dziegielewski Toward a Basic Understanding of the Substance-Related and Addictive Disorders 418 Understanding the Individuals Who Suffer From the Substance Disorders 419 Overview of the Substance-Related and Addictive Disorders 425 Beginning the Diagnostic Assessment: Alcohol-Related Disorders 436 Treatment Planning and Intervention Strategy 445 Brief Interventions in Primary Care Settings 453 Topics of Interest 456 Misuse of Prescription Medications 461 Summary and Future Directions 462 References 463 Chapter 13 Personality Disorders 467Sophia F. Dziegielewski and George A. Jacinto Introduction 467 Toward a Basic Understanding of the Personality Disorders 468 Understanding Individuals Suffering From a Personality Disorder 468 What Is a Personality Disorder? 471 Cluster A Personality Disorders 471 Cluster B Personality Disorders 475 Cluster C Personality Disorders 482 Other Personality Disorders 485 Summary of the Personality Disorders 487 Borderline Personality Disorder (BPD) 487 Strategies for Individual Therapy and Intervention 500 Section III: Alternative DSM-5 Model for the Personality Disorders 502 Summary and Future Directions 503 References 504 Appendix: Quick References: Selected Disorders—Criteria and Treatment Plans 507 Author Index 545 Subject Index 561 About the Author 583

Read more less

Book SynopsisBone Marrow Diagnosis, Third Edition, is an essential resource for pathologists and haematologists who need to report bone marrow trephine biopsies. Practical and highly illustrated this edition has been comprehensively updated whilst remaining succinct and concentrating on the core information necessary to make an accurate diagnosis. The text provides comparisons of the common methods of sample collection, fixation and staining, and a clear description of how to examine a trephine section. Applying a consistent approach, the chapters cover the range of disorders of bone marrow, discussing the clinical features, histopathology of bone marrow and diagnostic problems of each condition. Each chapter closes with a summary of key points and each diagnostic entity is accompanied by high quality images, over 900 in all, showing typical and more unusual examples of histological features. This compact text, oriented at diagnosis and comprehensively accompanied by Table of ContentsPreface to the third edition vi Preface to the first edition vii 1 Introduction 1 2 The normal bone marrow 4 3 Infections including human immunodeficiency virus 18 4 Anaemias and aplasias 32 5 The myelodysplastic syndromes 42 6 Myeloproliferative neoplasms 49 7 Acute leukaemia 69 8 Lymphomas: an overview 89 9 Precursor B and T lymphoblastic leukaemia (acute lymphoblastic leukaemia) and lymphoblastic lymphoma 101 10 Mature B cell neoplasms 108 11 Mature T and NK cell neoplasms 161 12 Hodgkin lymphoma 179 13 Metastatic disease 188 14 Bone stroma and miscellaneous changes 196 15 Technical considerations 209 Index 215

Read more less

Book SynopsisImmunohistochemistry and immunocytochemistry are invaluable tools for the visualization of tissue and cellular antigens in diagnostic and biological research environments. The need to obtain accurate, reliable and reproducible results is paramount.It is with this fundamental aim in mind that we have compiled Immunohistochemistry: Essential Methods. We have achieved this by examining each aspect of immunochemistry in turn, with each chapter including detailed information regarding the subject matter in question. Each chapter is written by an expert in their field and includes protocols that are typically used in their own research. Subjects covered are, amongst others, antibodies and their production; selection of reporter labels; immunochemical staining methods and experimental design (both using single and multiple reporter labels); quality assurance; automated immunochemistry; confocal microscopy and electron microscopy. In addition, benefits and limitations of each approTable of ContentsList of Contributors vii Preface ix Acknowledgements xi Chapter 1: Antibodies for Immunochemistry 1Mark Cooper and Sheriden Lummas Introduction 1 Immunogens for Antibody Production 5 Antibody Production 12 Antibody Purification 16 Fragment Antibody Preparations 20 Antibody Labelling 21 Antibody Stability and Storage 23 References 24 Chapter 2: The Selection of Reporter Labels 25Judith Langenick Introduction 25 Enzymatic Labels 26 Fluorescence Detection 29 References 32 Chapter 3: Immunohistochemistry and Immunocytochemistry 35Simon Renshaw Specimen Formats for Immunochemistry 36 Fixation 37 Processing Tissue Blocks to Paraffin Wax 46 Microtomy 47 Tissue Microarrays 47 Specimen Storage 48 Decalcification 49 Antigen Retrieval 50 Controls 56 Immunochemical Staining Techniques (Optimizing a New Antibody) 57 Counterstains 71 Mounting 74 Troubleshooting 76 Examples of Immunostaining Photomicrographs 76 Acknowledgements 101 References 101 Chapter 4: Multiple Immunochemical Staining Techniques 103Sofia Koch Introduction 103 Methods and Approaches 115 References 122 Chapter 5: Quality Assurance in Immunochemistry 123Peter Jackson and Michael Gandy Introduction 123 Methods and Approaches 125 Automated Immunochemical Staining 147 Troubleshooting 149 References 154 Chapter 6: Automated Immunochemistry 157Emanuel Schenck and Simon Renshaw Introduction 157 Methods and Approaches 160 Other Forms of Automation 164 References 168 Chapter 7: Confocal Microscopy 169Ann Wheeler Introduction 169 When Should Confocal be Used? 173 Applications: For Example Co-localization, Quantification, 3D Visualization and Kinetics 173 How To Set Up a Confocal Experiment? 174 References 198 Further Readings 198 Chapter 8: Ultrastructural Immunochemistry 199Jeremy Skepper and Janet Powell Introduction 199 Methods and Approaches 207 References 222 Index 227

Read more less

Book SynopsisDiagnosing Dental and Orofacial Pain: A Clinical Manual approaches a complex topic in a uniquely practical way. This text offers valuable advice on ways to observe and communicate effectively with patients in pain, how to analyze a patients' pain descriptions, and how to provide a proper diagnosis of orofacial pain problems that can arise from a myriad of sourcesanywhere from teeth, joint and muscle pain, and paranasal sinuses to cluster headaches, neuralgias, neuropathic pain and viral infections. Helps the student and practitioner understand the diagnostic process by addressing the exact questions that need to be asked and then analyzing verbal and non-verbal responses to these Edited by experts with decades of clinical and teaching experience, and with contributions from international specialists Companion website provides additional learning materials including videos, case studies and further practical tips for examination and diagnosis Table of ContentsContributors vi Acknowledgments vii About the Companion Website viii 1 Introduction 1 Alex J. Moule and M. Lamar Hicks 2 The Art of Listening – Communicating Effectively with a Patient in Pain 3 Andrew D. Wolvin 3 Causes of Pain in the Orofacial Region 6 Vishal R. Aggarwal, Alex J. Moule and M. Lamar Hicks 4 Gathering Information for an Accurate Pain Diagnosis 16 Alex J. Moule and M. Lamar Hicks 5 Analyzing Patients in Pain – Describing Pain and the Importance of Descriptors 19 Alex J. Moule and M. Lamar Hicks 6 Analyzing Patients in Pain – Observing Patients in Pain 23 Alex J. Moule and Tareq Al Ali 7 Analyzing Patients in Pain – Associations with Cold and Heat 36 Alex J. Moule and M. Lamar Hicks 8 Analyzing Pain Descriptions – Pain on Biting or Eating and Other Considerations 41 Alex J. Moule and M. Lamar Hicks 9 Analyzing Pain Descriptions – Time Analysis and the Diagnosis of Orofacial Pain 46 Alex J. Moule and M. Lamar Hicks 10 Analyzing Pain Descriptions – Factors Influencing the Pain 50 Alex J. Moule and M. Lamar Hicks 11 Tests and Testing 53 Alex J. Moule and Unni Krishnan 12 Diagnosing Dental Pain 61 Alex J. Moule and Unni Krishnan 13 Diagnosing Cracked (Crown Fractured) Teeth 68 Alex J. Moule 14 Diagnosing Joint and Muscle Pains 79 Chris Moule and Iven Klineberg 15 Diagnosing Pain Referral from Neck and Shoulders 89 Scott Cook and Alex J. Moule 16 Diagnosing Pain from the Sinuses 96 Unni Krishnan and Alex J. Moule 17 Diagnosing Tension Headaches and Migraine 103 David Mock 18 Diagnosing Cluster Headaches 106 Kerryn Green 19 Diagnosing Trigeminal Neuralgia 109 Kerryn Green 20 Viruses as a Cause of Orofacial Pain 113 Michael Apicella 21 Vascular Causes of Headaches 117 Mark Paine 22 Diagnosing Neuropathic Orofacial Pain 123 E. Russell Vickers and Alex J. Moule 23 Referral Strategies for Orofacial Pain Cases 130 F. Russell Vickers and Alex J. Moule References 133 Index 140

Read more less

Book SynopsisA concise, quick-reference handbook on history taking and physical examination Pocket Guide to Physical Assessmentis a compact yet comprehensive reference for students and practitioners alike, employing a step-by-step framework for effective patient assessment, diagnosis and planning of care. This valuable guide covers topics including cardiovascular, respiratory, neurological and musculoskeletal system examinations, patient interviews, history taking and general health assessments. Clear diagrams and checklists illustrate key points, while easy-to-follow instructions and concise descriptions of clinical situations and diseases aid in clinical decision-making. Compact, pocket-sized guide that contains only the essential information for physical assessmentInstructs readers on best clinical practice and how to present and communicate casesDevelops and improves necessary skills for physical clinical examinationsIdeal for use on the ward or as a companion to the accompanying textbookTable of ContentsContributors vii Foreword ix Preface xi Acknowledgements xiii 1 Interviewing and History Taking 1Carol Lynn Cox 2 General Health Assessment 29Carol Lynn Cox 3 Basic Examination, Notes, and Diagnostic Principles 61Carol Lynn Cox 4 Examination of the Cardiovascular System 75Carol Lynn Cox 5 Examination of the Respiratory System 105Carol Lynn Cox 6 Examination of the Abdomen 127Anthony McGrath 7 Examination of the Male Genitalia 149Carol Lynn Cox and Anthony McGrath 8 Examination of the Female Genitalia 161Victoria Lack 9 Examination of the Nervous System 185Graham M Boswell 10 Examination of the Eye 235Helen Gibbons 11 Examination of the Musculoskeletal System 265Nicola L Whiteing 12 Presenting Cases and Communication 297Carol Lynn Cox Appendix A Jaeger Reading Chart 311 Appendix B Visual Acuity 3 Meter/21 Foot Chart 313 Appendix C Hodkinson Ten-Point Mental Test Score 315 Appendix D Barthel Index of Activities of Daily Living 317 Appendix E Mini-Mental State Examination (MMSE) 321 Appendix F Glasgow Coma Scale 325 Appendix G Warnings Signs of Alzheimer’s Disease 327 Appendix H Trigger Symptoms Indicative of Dementia 329 Appendix I The 12-Lead Electrocardiogram 331 Index 369

Read more less

Book SynopsisOffers clear and concise instruction on running, reporting and interpreting immunophenotyping studies Written by two well-known haematology educators and experts on the topic, Immunophenotyping for Haematologists contains an introduction to running, reporting and interpreting immunophenotyping studies. The book offers a unique approach to the topic by putting the focus on clinical and laboratory haematologists who are not routinely involved in running and reporting on immunophenotyping studies. Immunophenotyping using flow cytometry has become the method of choice in identifying and sorting cells within complex populations, for example, the analysis of immune or neoplastic cells in a blood sample. The text reviews the purpose and principles of immunophenotyping and includes an introduction and explanation of the principles and the role of immunophenotyping. The authors examine immunophenotypic characteristics of the disease groups commonly encountered andTable of ContentsPreface and Acknowledgement vii Abbreviations Used in the Book ix Part 1 Purpose and Principles of Immunophenotyping 1 Part 2 Immunophenotyping for Haematologists 11 Part 3 Immunophenotyping in the Diagnosis and Monitoring of Haematological Neoplasms and Related Conditions with Tables and Figures for Quick Reference 47 Part 4 Test Yourself 89 Index 127

Read more less

Book Synopsis

Read more less

Book SynopsisTable of ContentsContributors xv Preface xix Part One About Cochrane Reviews of diagnostic test accuracy 1 1 Planning a Cochrane Review of diagnostic test accuracy 3 1.1 Introduction 4 1.2 Why do a systematic review of test accuracy? 4 1.3 Undertaking a Cochrane Review of diagnostic test accuracy 5 1.3.1 The role of the Diagnostic Test Accuracy Editorial Team 5 1.3.2 Expectations for the conduct and reporting of Cochrane Reviews of diagnostic test accuracy 5 1.3.3 Data management and quality assurance 6 1.3.4 Keeping the Review up to date 6 1.4 Proposing a new Cochrane Review of diagnostic test accuracy 6 1.5 Cochrane Protocols 7 1.6 The author team 11 1.6.1 The importance of the team 11 1.6.2 Criteria for authorship 12 1.6.3 Incorporating relevant perspectives and stakeholder involvement 12 1.7 Resources and support 13 1.7.1 Identifying resources and support 13 1.7.2 Funding and conflicts of interest 14 1.7.3 Training 14 1.7.4 Software 15 1.8 Chapter information 15 1.9 References 16 Part Two Introducing test accuracy 19 2 Evaluating medical tests 21 2.1 Introduction 21 2.2 Types of medical tests 22 2.3 Test accuracy 23 2.4 How do diagnostic tests affect patient outcomes? 24 2.4.1 Direct test effects 25 2.4.2 Altering clinical decisions and actions 25 2.4.3 Changes to time frames and populations 25 2.4.4 Influencing patient and clinician perceptions 26 2.5 Evaluations of test accuracy during test development 26 2.5.1 Evaluations of accuracy during biomarker discovery 26 2.5.2 Early evaluations of test accuracy 27 2.5.3 Clinical evaluations of test accuracy 28 2.6 Other purposes of medical testing 28 2.6.1 Predisposition 29 2.6.2 Risk stratification 29 2.6.3 Screening 29 2.6.4 Staging 29 2.6.5 Prognosis 30 2.6.6 Treatment selection 30 2.6.7 Treatment efficacy 31 2.6.8 Therapeutic monitoring 31 2.6.9 Surveillance for progression or recurrence 31 2.7 Chapter information 32 2.8 References 32 3 Understanding the design of test accuracy studies 35 3.1 Introduction 35 3.2 The basic design for a test accuracy study 36 3.3 Multiple groups of participants 39 3.4 Multiple reference standards 42 3.5 More on reference standards 44 3.5.1 Delayed verification 44 3.5.2 Composite reference standard 44 3.5.3 Panel- based reference 44 3.5.4 Latent class analysis 45 3.5.5 Gold standard 45 3.5.6 Clinical reference standard 45 3.6 Comparative test accuracy studies 45 3.6.1 Paired comparative accuracy study 46 3.6.2 Randomized comparative accuracy study 46 3.6.3 Non- randomized comparative accuracy study 47 3.7 Additional aspects of study designs 47 3.7.1 Prospective versus retrospective 48 3.7.2 Pragmatic versus explanatory 48 3.8 Concluding remarks 49 3.9 Chapter information 49 3.10 References 50 4 Understanding test accuracy measures 53 4.1 Introduction 53 4.2 Types of test data 54 4.3 Inconclusive index test results 55 4.4 Target condition 56 4.5 Analysis of a primary test accuracy study 56 4.5.1 Sensitivity and specificity 57 4.5.2 Predictive values 58 4.5.3 Proportion with the target condition 58 4.5.4 Pre- test and post- test probabilities 59 4.5.5 Interpretation of sensitivity, specificity and predictive values 59 4.5.6 Confidence intervals 60 4.5.7 Other test accuracy measures 61 4.6 Positivity thresholds 64 4.7 Receiver operating characteristic curves 66 4.8 Analysis of a comparative accuracy study 68 4.9 Chapter information 71 4.10 References 72 Part Three Methods and presentation of systematic reviews of test accuracy 73 5 Defining the review question 75 5.1 Introduction 75 5.2 Aims of systematic reviews of test accuracy 76 5.2.1 Investigations of heterogeneity 77 5.3 Identifying the clinical problem 77 5.3.1 Role of a new test 77 5.3.2 Defining the clinical pathway 80 5.3.3 Unclear and multiple clinical pathways 83 5.4 Defining the review question 84 5.4.1 Population 84 5.4.2 Index test(s) 85 5.4.3 Target condition 85 5.4.4 The review question: PIT 86 5.4.5 From review question to objectives 86 5.4.6 Broad versus narrow questions 87 5.5 Defining eligibility criteria 88 5.5.1 Types of studies 88 5.5.2 Participants 89 5.5.3 Index test(s) 90 5.5.4 Target condition 91 5.5.5 Reference standard 92 5.6 Chapter information 93 5.7 References 93 6 Searching for and selecting studies 97 6.1 Introduction 98 6.2 Searching for studies 98 6.2.1 Working in partnership 100 6.2.2 Advice for review teams that do not include an information specialist 101 6.3 Sources to search 101 6.3.1 Bibliographic databases 101 6.3.1.1 MEDLINE, PubMed and Embase 102 6.3.1.2 National and regional databases 103 6.3.1.3 Subject- specific databases 103 6.3.1.4 Dissertations and theses databases 104 6.3.2 Additional sources to search 104 6.3.2.1 Related reviews, guidelines and reference lists as sources of studies 105 6.3.2.2 Handsearching 105 6.3.2.3 Forward citation searching and co- citation searching 105 6.3.2.4 Web searching 106 6.3.2.5 Grey literature databases 107 6.3.2.6 Trial registries 107 6.3.2.7 Contacting colleagues, study authors and manufacturers 108 6.4 Designing search strategies 108 6.4.1 Structuring the search strategy 109 6.4.2 Controlled vocabulary and text words 110 6.4.3 Text word or keyword searching 112 6.4.4 Search filters 113 6.4.5 Language, date and type of document restrictions 113 6.4.6 Identifying fraudulent studies, other retracted publications, errata and comments 114 6.4.7 Minimizing the risk of bias through search methods 114 6.5 Documenting and reporting the search process 115 6.5.1 Documenting the search process 116 6.5.2 Reporting the search process 116 6.5.2.1 Reporting the search process in the protocol 116 6.5.2.2 Reporting the search process in the review 117 6.6 Selecting relevant studies 119 6.6.1 Examine full- text reports for compliance of studies with eligibility criteria 120 6.7 Future developments in literature searching and selection 121 6.8 Chapter information 121 6.9 References 122 7 Collecting data 131 7.1 Introduction 132 7.2 Sources of data 132 7.2.1 Studies (not reports) as the unit of interest 133 7.2.2 Correspondence with investigators 134 7.3 What data to collect 135 7.3.1 What are data? 135 7.3.2 Study methods (participant recruitment and sampling) 137 7.3.3 Participant characteristics and setting 138 7.3.4 Index test(s) 139 7.3.5 Target condition and reference standard 140 7.3.6 Flow and timing 140 7.3.7 Extracting study results and converting to the desired format 141 7.3.7.1 Obtaining 2×2 data from accuracy measures 141 7.3.7.2 Using global measures 144 7.3.7.3 Challenges defining reference standard positive and negative: strategies when there are more than two categories 145 7.3.7.4 Challenges defining index test positive and negative: inconclusive results 145 7.3.7.5 Challenges defining index test positive and negative: test failures 147 7.3.7.6 Challenges defining index test positive and negative: dealing with multiple thresholds and extracting data from ROC curves or other graphics 147 7.3.7.7 Extracting data from figures with software 148 7.3.7.8 Corrections for missing data: adjusting for partial verification bias 148 7.3.7.9 Multiple index tests from the same study 148 7.3.7.10 Subgroups of patients 150 7.3.7.11 Individual patient data 150 7.3.7.12 Extracting covariates 151 7.3.8 Other information to collect 151 7.4 Data collection tools 152 7.4.1 Rationale for data collection forms 152 7.4.2 Considerations in selecting data collection tools 152 7.4.3 Design of a data collection form 154 7.5 Extracting data from reports 157 7.5.1 Introduction 157 7.5.2 Who should extract data? 157 7.5.3 Training data extractors 158 7.5.4 Extracting data from multiple reports of the same study 158 7.5.5 Reliability and reaching consensus 159 7.5.6 Suspicions of scientific misconduct 159 7.5.7 Key points in planning and reporting data extraction 160 7.6 Managing and sharing data and tools 160 7.7 Chapter information 163 7.8 References 164 8 Assessing risk of bias and applicability 169 8.1 Introduction 170 8.2 Understanding bias and applicability 171 8.2.1 Bias and imprecision 171 8.2.2 Bias versus applicability 171 8.2.3 Biases in test accuracy studies: empirical evidence 172 8.3 Quadas- 2 173 8.3.1 Background 173 8.3.2 Risk- of- bias assessment 173 8.3.3 Applicability assessment 174 8.3.4 Using and tailoring QUADAS- 2 174 8.3.5 Flow diagram 174 8.3.6 Performing the QUADAS- 2 assessment 175 8.4 Domain 1: Participant selection 176 8.4.1 Participant selection: risk- of- bias signalling questions (QUADAS- 2) 176 8.4.2 Participant selection: additional signalling questions for comparative accuracy studies (QUADAS- C) 178 8.4.3 Participant selection: concerns regarding applicability 181 8.5 Domain 2: Index test 182 8.5.1 Index test: risk- of- bias signalling questions (QUADAS- 2) 182 8.5.2 Index test: additional signalling questions for comparative accuracy studies (QUADAS- C) 183 8.5.3 Index test: concerns regarding applicability 186 8.6 Domain 3: Reference standard 187 8.6.1 Reference standard: risk- of- bias signalling questions (QUADAS- 2) 187 8.6.2 Reference standard: additional signalling questions for comparative accuracy studies (QUADAS- C) 188 8.6.3 Reference standard: concerns regarding applicability 189 8.7 Domain 4: Flow and timing 191 8.7.1 Flow and timing: risk- of- bias signalling questions (QUADAS- 2) 191 8.7.2 Flow and timing: additional signalling questions for comparative accuracy studies (QUADAS- C) 193 8.8 Presentation of risk- of- bias and applicability assessments 196 8.9 Narrative summary of risk- of- bias and applicability assessments 197 8.10 Chapter information 197 8.11 References 198 9 Understanding meta- analysis 203 9.1 Introduction 203 9.1.1 Aims of meta- analysis for systematic reviews of test accuracy 204 9.1.2 When not to use a meta- analysis in a review 204 9.1.3 How does meta- analysis of diagnostic test accuracy differ from metaanalysis of interventions? 205 9.1.4 Questions that can be addressed in test accuracy analyses 206 9.1.4.1 What is the accuracy of a test? 206 9.1.4.2 How does the accuracy vary with clinical and methodological characteristics? 206 9.1.4.3 How does the accuracy of two or more tests compare? 206 9.1.5 Planning the analysis 207 9.2 Graphical and tabular presentation 208 9.2.1 Coupled forest plots 208 9.2.2 Summary ROC plots 208 9.2.3 Linked SROC plots 210 9.2.3.1 Example 1: Anti- CCP for the diagnosis of rheumatoid arthritis – descriptive plots 210 9.2.4 Tables of results 211 9.3 Meta- analytical summaries 211 9.3.1 Should I estimate an SROC curve or a summary point? 212 9.3.2 Heterogeneity 214 9.4 Fitting hierarchical models 215 9.4.1 Bivariate model 216 9.4.2 Example 1 continued: anti- CCP for the diagnosis of rheumatoid arthritis 217 9.4.3 The Rutter and Gatsonis HSROC model 219 9.4.4 Example 2: Rheumatoid factor as a marker for rheumatoid arthritis 220 9.4.5 Data reported at multiple thresholds per study 221 9.4.6 Investigating heterogeneity 222 9.4.6.1 Criteria for model selection 223 9.4.6.2 Heterogeneity and regression analysis using the bivariate model 223 9.4.6.3 Example 1 continued: Investigation of heterogeneity in diagnostic performance of anti- CCP 224 9.4.6.4 Heterogeneity and regression analysis using the Rutter and Gatsonis HSROC model 227 9.4.6.5 Example 2 continued: Investigating heterogeneity in diagnostic accuracy of rheumatoid factor (RF) 228 9.4.7 Comparing index tests 230 9.4.7.1 Test comparisons based on all available studies 230 9.4.7.2 Test comparisons using the bivariate model 231 9.4.7.3 Example 3: CT versus MRI for the diagnosis of coronary artery disease 232 9.4.7.4 Test comparisons using the Rutter and Gatsonis HSROC model 234 9.4.7.5 Test comparison based on studies that directly compare tests 235 9.4.7.6 Example 3 continued: CT versus MRI for the diagnosis of coronary artery disease 236 9.4.8 Approaches to analysis with small numbers of studies 238 9.4.9 Sensitivity analysis 239 9.5 Special topics 241 9.5.1 Imperfect reference standard 241 9.5.2 Investigating and handling verification bias 241 9.5.3 Investigating and handling publication bias 242 9.5.4 Developments in meta- analysis for systematic reviews of test accuracy 243 9.6 Chapter information 243 9.7 References 244 10 Undertaking meta- analysis 249 10.1 Introduction 249 10.2 Estimation of a summary point 251 10.2.1 Fitting the bivariate model using SAS 251 10.2.2 Fitting the bivariate model using Stata 253 10.2.3 Fitting the bivariate model using R 256 10.2.4 Bayesian estimation of the bivariate model 261 10.2.4.1 Specification of the bivariate model in rjags 261 10.2.4.2 Monitoring convergence 263 10.2.4.3 Summary statistics 264 10.2.4.4 Generating an SROC plot 265 10.2.4.5 Sensitivity analyses 266 10.3 Estimation of a summary curve 266 10.3.1 Fitting the HSROC model using SAS 268 10.3.2 Bayesian estimation of the HSROC model 268 10.3.2.1 Specification of the HSROC model in rjags 268 10.3.2.2 Monitoring convergence 270 10.3.2.3 Summary statistics and SROC plot 271 10.3.2.4 Sensitivity analyses 272 10.4 Comparison of summary points 272 10.4.1 Fitting the bivariate model in SAS to compare summary points 274 10.4.2 Fitting the bivariate model in Stata to compare summary points 280 10.4.3 Fitting the bivariate model in R to compare summary points 284 10.4.4 Bayesian inference for comparing summary points 287 10.4.4.1 Summary statistics 289 10.5 Comparison of summary curves 291 10.5.1 Fitting the HSROC model in SAS to compare summary curves 292 10.5.2 Bayesian estimation of the HSROC model for comparing summary curves 294 10.5.2.1 Monitoring convergence 295 10.5.2.2 Summary statistics 295 10.6 Meta- analysis of sparse data and a typical data sets 296 10.6.1 Facilitating convergence 297 10.6.2 Simplifying hierarchical models 301 10.7 Meta- analysis with multiple thresholds per study 305 10.7.1 Meta- analysis of multiple thresholds with R 306 10.7.2 Meta- analysis of multiple thresholds with rjags 311 10.8 Meta- analysis with imperfect reference standard: latent class meta- analysis 316 10.8.1 Specification of the latent class bivariate meta- analysis model in rjags 316 10.8.2 Monitoring convergence 317 10.8.3 Summary statistics and summary ROC plot 317 10.8.4 Sensitivity analyses 320 10.9 Concluding remarks 321 10.10 Chapter information 321 10.11 References 322 11 Presenting findings 327 11.1 Introduction 327 11.2 Results of the search 328 11.3 Description of included studies 328 11.4 Methodological quality of included studies 329 11.5 Individual and summary estimates of test accuracy 329 11.5.1 Presenting results from included studies 330 11.5.2 Presenting summary estimates of sensitivity and specificity 330 11.5.3 Presenting SROC curves 330 11.5.4 Describing uncertainty in summary statistics 332 11.5.5 Describing heterogeneity in summary statistics 333 11.6 Comparisons of test accuracy 333 11.6.1 Comparing tests using summary points 333 11.6.2 Comparing tests using SROC curves 334 11.6.3 Interpretation of confidence intervals for differences in test accuracy 336 11.7 Investigations of sources of heterogeneity 336 11.8 Re- expressing summary estimates numerically 340 11.8.1 Frequencies 340 11.8.2 Predictive values 341 11.8.3 Likelihood ratios 344 11.9 Presenting findings when meta- analysis cannot be performed 344 11.10 Chapter information 346 11.11 References 347 12 Drawing conclusions 349 12.1 Introduction 349 12.2 ‘Summary of findings’ tables 350 12.3 Assessing the strength of the evidence 352 12.3.1 Key issues to consider when assessing the strength of the evidence 352 12.3.1.1 How valid are the summary estimates? 359 12.3.1.2 How applicable are the summary estimates? 359 12.3.1.3 How heterogeneous are the individual study estimates? 359 12.3.1.4 How precise are the summary estimates? 360 12.3.1.5 How complete is the body of evidence? 361 12.3.1.6 Were index test comparisons made between or within primary studies? 362 12.4 GRADE approach for assessing the certainty of evidence 362 12.4.1 GRADE domains for assessing certainty of evidence for test accuracy 363 12.4.1.1 Risk of bias 363 12.4.1.2 Indirectness (applicability) 363 12.4.1.3 Inconsistency (heterogeneity) 364 12.4.1.4 Imprecision 365 12.4.1.5 Publication bias 365 12.5 Summary of main results in the Discussion section 365 12.6 Strengths and weaknesses of the review 366 12.6.1 Strengths and weaknesses of included studies 366 12.6.2 Strengths and weaknesses of the review 367 12.6.2.1 Strengths and weaknesses due to the search and selection process 367 12.6.2.2 Strengths and weaknesses due to methodological quality assessment and data extraction 367 12.6.2.3 Weaknesses due to the review analyses 368 12.6.2.4 Direct and indirect comparisons 368 12.6.3 Comparisons with previous research 369 12.7 Applicability of findings to the review question 369 12.8 Drawing conclusions 369 12.8.1 Implications for practice 370 12.8.2 Implications for research 373 12.9 Chapter information 374 12.10 References 374 13 Writing a plain language summary 377 13.1 Introduction 377 13.2 Audience and writing style 378 13.3 Contents and structure of a plain language summary 379 13.3.1 Title 380 13.3.2 Key messages 380 13.3.3 ‘Why is improving [ ] diagnosis important?’ 381 13.3.4 ‘What is the [ ] test?’ 382 13.3.5 What did we want to find out? 382 13.3.6 What did we do? 383 13.3.7 What did we find? 383 13.3.7.1 Describing the included studies 383 13.3.7.2 Presenting information on test accuracy 384 13.3.7.3 Presenting single estimates of accuracy 385 13.3.7.4 Presenting multiple estimates of accuracy: two index tests 386 13.3.7.5 Presenting multiple estimates of accuracy: more than two index tests 387 13.3.7.6 When presenting a numerical summary of test accuracy is not appropriate 387 13.3.7.7 Graphical illustration of test accuracy results 388 13.3.8 What are the limitations of the evidence? 391 13.3.9 How up to date is this evidence? 392 13.4 Chapter information 392 13.5 References 393 13.6 Appendix: Additional example plain language summary 394 Index 399

Read more less

Book SynopsisIntegrating detailed methodology with basic interpretation of the commonly encountered diagnostic problems in electron microscopy, Diagnostic Electron Microscopy provides a basic stand-alone diagnostic 'how to' book.Trade Review“Thus, this book is a “must-have” for all pathology departments, even if they are not equipped with an EM facility, and it is also a solid proof of the current role of electron microscopy in health care.” (Microscopy & Microanalysis, 1 August 2013)Table of ContentsList of Contributors xvii Preface – Introduction xxi 1 Renal Disease 1 John W. Stirling and Alan Curry 1.1 The Role of Transmission Electron Microscopy (TEM) in Renal Diagnostics 1 1.2 Ultrastructural Evaluation and Interpretation 2 1.3 The Normal Glomerulus 3 1.3.1 The Glomerular Basement Membrane 4 1.4 Ultrastructural Diagnostic Features 5 1.4.1 Deposits: General Features 5 1.4.2 Granular and Amorphous Deposits 6 1.4.3 Organised Deposits: Fibrils and Tubules 7 1.4.4 Nonspecific Fibrils 11 1.4.5 General and Nonspecific Inclusions and Deposits 11 1.4.6 Fibrin 12 1.4.7 Tubuloreticular Bodies (Tubuloreticular Inclusions) 12 1.4.8 The Glomerular Basement Membrane 13 1.4.9 The Mesangial Matrix 14 1.4.10 Cellular Components of the Glomerulus 14 1.4.11 Parietal Epithelium 16 1.5 The Ultrastructural Pathology of the Major Glomerular Diseases 16 1.5.1 Diseases without, or with Only Minor, Structural GBM Changes 16 1.5.2 Diseases with Structural GBM Changes 19 1.5.3 Diseases with Granular Deposits 25 1.5.4 Diseases with Organised Deposits 40 1.5.5 Hereditary Metabolic Storage Disorders 46 References 47 2 Transplant Renal Biopsies 55 John Brealey 2.1 Introduction 55 2.2 The Transplant Renal Biopsy 55 2.3 Indications for Electron Microscopy of Transplant Kidney 56 2.3.1 Transplant Glomerulopathy 56 2.3.2 Recurrent Primary Disease 64 2.3.3 De Novo Glomerular Disease 72 2.3.4 Donor-Related Disease 74 2.3.5 Infection 74 2.3.6 Inconclusive Diagnosis by LM and/or IM 79 2.3.7 Miscellaneous Topics 81 References 84 3 Electron Microscopy in Skeletal Muscle Pathology 89 Elizabeth Curtis and Caroline Sewry 3.1 Introduction 89 3.1.1 The Biopsy Procedure 90 3.1.2 Sampling 90 3.1.3 Tissue Processing 90 3.1.4 Artefacts 91 3.2 Normal Muscle 91 3.3 Pathological Changes 96 3.3.1 Sarcolemma 96 3.3.2 Myofibrils 99 3.3.3 Glycogen 102 3.3.4 Cores 104 3.3.5 Target Fibres 105 3.3.6 Myonuclei 105 3.3.7 Mitochondria 106 3.3.8 Reticular System 108 3.3.9 Vacuoles 109 3.3.10 Capillaries 110 3.3.11 Other Structural Defects 111 References 113 4 The Diagnostic Electron Microscopy of Nerve 117 Rosalind King 4.1 Introduction 117 4.2 Tissue Processing 118 4.2.1 Preparation of Nerve Biopsy Specimens 118 4.3 Normal Nerve Ultrastructure 120 4.3.1 Axons 120 4.3.2 Schwann Cells 120 4.3.3 The Myelin Sheath 120 4.3.4 Node of Ranvier 122 4.3.5 Paranode 123 4.3.6 Juxtaparanode 123 4.3.7 Internode 123 4.3.8 Schmidt–Lanterman Incisures 124 4.3.9 Remak Fibres 124 4.3.10 Fibroblasts 124 4.3.11 Renaut Bodies 125 4.4 Pathological Ultrastructural Features 125 4.4.1 Axonal Degeneration 125 4.4.2 Axonal Regeneration 126 4.4.3 Remak Fibre Abnormalities 128 4.4.4 Polyglucosan Bodies 128 4.4.5 Nonspecific Axonal Inclusions 128 4.4.6 Demyelination and Remyelination 130 4.4.7 Specific Schwann Cell Inclusions 135 4.4.8 Nonspecific Schwann Cell Inclusions 136 4.4.9 Fibroblasts 142 4.4.10 Perineurial Abnormalities 142 4.4.11 Cellular Infiltration 143 4.4.12 Endoneurial Oedema 143 4.4.13 Connective Tissue Abnormalities 143 4.4.14 Endoneurial Blood Vessels 145 4.4.15 Mast Cells 145 4.5 Artefact 145 4.6 Conclusions 147 References 148 5 The Diagnostic Electron Microscopy of Tumours 153 Brian Eyden 5.1 Introduction 153 5.2 Principles and Procedures for Diagnosing Tumours by Electron Microscopy 154 5.2.1 The Objective of Tumour Diagnosis 154 5.2.2 The Intellectual Requirements for Tumour Diagnosis by Electron Microscopy 155 5.2.3 Technical Considerations 156 5.2.4 Identifying Good Preservation 158 5.2.5 Distinguishing Reactive from Neoplastic Cells 162 5.3 Organelles and Groups of Cell Structures Defining Cellular Differentiation 162 5.3.1 Rough Endoplasmic Reticulum 162 5.3.2 Melanosomes 165 5.3.3 Desmosomes 167 5.3.4 Tonofibrils 167 5.3.5 Basal Lamina 169 5.3.6 Glandular Epithelial Differentiation and Cell Processes 171 5.3.7 Neuroendocrine Granules 171 5.3.8 Smooth-Muscle Myofilaments 173 5.3.9 Sarcomeric Myofilaments (Thick-and-Thin Filaments with Z-Disks) 176 References 178 6 Microbial Ultrastructure 181 Alan Curry 6.1 Introduction 181 6.2 Practical Guidance 182 6.3 Viruses 183 6.4 Current Use of EM in Virology 185 6.5 Viruses in Thin Sections of Cells or Tissues 186 6.6 Bacteria 191 6.7 Fungal Organisms 194 6.8 Microsporidia 196 6.9 Parasitic Protozoa 206 6.9.1 Cryptosporidium 207 6.9.2 Isospora belli 211 6.10 Examples of Non-enteric Protozoa 212 6.11 Parasitic Amoebae 213 6.12 Conclusions 214 Acknowledgements 214 References and Additional Reading 214 7 The Contemporary Use of Electron Microscopy in the Diagnosis of Ciliary Disorders and Sperm Centriolar Abnormalities 221 P. Yiallouros, M. Nearchou, A. Hadjisavvas and K. Kyriacou 7.1 Introduction 221 7.2 Ultrastructure of Motile Cilia 224 7.3 Genetics of PCD 226 7.4 Current Diagnostic Modalities 228 7.5 Clinical Features 229 7.6 Procurement and Assessment of Ciliated Specimens 230 7.7 Centriolar Sperm Abnormalities 231 7.8 Discussion 232 Acknowledgements 234 References 234 8 Electron Microscopy as a Useful Tool in the Diagnosis of Lysosomal Storage Diseases 237 Joseph Alroy, Rolf Pfannl and Angelo A. Ucci 8.1 Introduction 237 8.2 Morphological Findings 247 8.3 Conclusion 261 References 262 9 Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) 269 John W. Stirling 9.1 Introduction 269 9.2 Diagnostic Strategies – Comparative Specificity and Sensitivity 271 9.3 Diagnosis by TEM 271 References 274 10 Diagnosis of Platelet Disorders by Electron Microscopy 277 Hilary Christensen and Walter H.A. Kahr 10.1 Introduction 277 10.2 TEM Preparation of Platelets 278 10.3 Whole-Mount EM Preparation of Platelets 280 10.4 EM Preparation of Bone Marrow 281 10.5 Pre-embed Immunogold Labelling of Von Willibrand Factor in Platelets 282 10.6 Ultrastructural Features of Platelets 282 10.7 Normal Platelets 283 10.8 Grey Platelet Syndrome 285 10.9 Arthrogryposis, Renal Dysfunction and Cholestasis Syndrome 285 10.10 Jacobsen Syndrome 285 10.11 Hermansky–Pudlak Syndrome, Chediak–Higashi Syndrome and Other Dense-Granule Deficiencies 287 10.12 Type 2B von Willebrand Disease and Platelet-Type von Willebrand Disease 288 References 290 11 Diagnosis of Congenital Dyserythropoietic Anaemia Types I and II by Transmission Electron Microscopy 293 Yong-xin Ru 11.1 Introduction 293 11.2 Preparation of Bone Marrow and General Observation Protocol 294 11.3 CDA Type I 294 11.3.1 Proerythroblasts and Basophilic Erythroblasts 294 11.3.2 Polychromatic and Orthochromatic Erythroblasts 295 11.3.3 Reticulocytes and Erythrocytes 299 11.4 CDA Type II 299 11.4.1 Erythroblasts 301 11.4.2 Erythrocytes 306 11.5 Summary 306 Acknowledgements 307 References 307 12 Ehlers–Danlos Syndrome 309 Trinh Hermanns-Lê, Marie-Annick Reginster, Claudine Piérard-Franchimont and Gérald E. Piérard 12.1 Introduction 309 12.2 Collagen Fibrils 310 12.3 Elastic Fibers 310 12.4 Nonfibrous Stroma and Granulo-Filamentous Deposits 311 12.5 Connective Tissue Disorders 311 12.5.1 Ehlers–Danlos Syndrome 311 12.5.2 Spontaneous Cervical Artery Dissection 317 12.5.3 Recurrent Preterm Premature Rupture of Fetal Membrane Syndrome 319 References 319 13 Electron Microscopy in Occupational and Environmental Lung Disease 323 Victor L. Roggli 13.1 Introduction 323 13.2 Asbestos 324 13.2.1 Preparatory Techniques 324 13.2.2 Analytical Methodology 326 13.2.3 Asbestos-Related Diseases 326 13.2.4 Exposure Categories 330 13.3 Hypersensitivity Pneumonitis and Sarcoidosis 330 13.3.1 Preparatory Techniques and Analytical Methodology 331 13.4 Silicosis 331 13.4.1 Preparatory Techniques and Analytical Methodology 333 13.5 Silicate Pneumoconiosis 333 13.5.1 Talc Pneumoconiosis 333 13.5.2 Kaolin Worker’s Pneumoconiosis 334 13.5.3 Mica and Feldspar Pneumoconiosis 334 13.5.4 Mixed Dust Pneumoconiosis 335 13.5.5 Preparatory Techniques and Analytical Methodology 335 13.6 Metal-Induced Diseases 335 13.6.1 Siderosis 336 13.6.2 Aluminosis 336 13.6.3 Hard Metal Lung Disease 336 13.6.4 Berylliosis 337 13.6.5 Preparatory Techniques and Analytical Methodology 337 13.7 Rare-Earth Pneumoconiosis 338 13.8 Miscellaneous Disorders 338 References 339 14 General Tissue Preparation Methods 341 John W. Stirling 14.1 Introduction 341 14.1.1 Specimens Suitable for Diagnostic TEM 341 14.2 Tissue Collection and Dissection 342 14.2.1 Tissue Cut-Up 343 14.3 Tissue Processing 345 14.3.1 Fixatives and Fixation 345 14.3.2 Primary Fixation: Glutaraldehyde 347 14.3.3 Secondary Fixation (Post-fixation): Osmium Tetroxide 347 14.3.4 Fixative Vehicles and Wash Buffers 347 14.3.5 En Bloc Staining with Uranyl Acetate 348 14.3.6 Dehydrant and Transition Fluids 348 14.3.7 Resin Infiltration and Embedding Media 349 14.3.8 Tissue Embedding 352 14.4 Tissue Sectioning 352 14.4.1 Ultramicrotomy 352 14.4.2 Sectioning Technique and Ultramicrotome Setup 355 14.4.3 Common Sectioning Problems and Artefacts 356 14.4.4 Section Staining 362 14.4.5 Section Contamination and Staining Artefacts 363 Protocol 364 Processing Schedules 364 References 379 15 Ultrastructural Pathology Today – Paradigm Change and the Impact of Microwave Technology and Telemicroscopy 383 Josef A. Schroeder 15.1 Diagnostic Electron Microscopy and Paradigm Shift in Pathology 383 15.2 Standardised and Automated Conventional Tissue Processing 385 15.3 Microwave-Assisted Sample Preparation 390 15.4 Cyberspace for Telepathology via the Internet 397 15.5 Conclusions and Future Prospects 400 Acknowledgements 404 References 404 16 Electron Microscopy Methods in Virology 409 Alan Curry 16.1 Biological Safety Precautions 409 16.2 Collection of Specimens 410 16.3 Preparation of Faeces, Vomitus or Urine Samples 410 16.4 Viruses in Skin Lesions 410 16.5 Reagents and Methods 411 16.5.1 Negative Stains 411 16.6 Coated Grids 412 16.7 Important Elements in the Negative Staining Procedure 412 16.8 TEM Examination 413 16.9 Immunoelectron Microscopy 413 16.9.1 Immune Clumping 413 16.9.2 Solid-Phase Immunoelectron Microscopy 413 16.9.3 Immunogold Labelling 414 16.9.4 Particle Measurement 414 16.10 Thin Sectioning of Virus-Infected Cells or Tissues 414 16.11 Virology Quality Assurance (QA) Procedures 415 16.11.1 External QA 415 16.11.2 Internal QA 415 Acknowledgements 415 References 416 17 Digital Imaging for Diagnostic Transmission Electron Microscopy 419 Gary Paul Edwards 17.1 Introduction 419 17.2 Camera History 419 17.3 The Pixel Dilemma 420 17.4 Camera Positioning 421 17.5 Resolution 422 17.6 Fibre Coupled or Lens Coupled? 423 17.7 Sensitivity, Noise and Dynamic Range 424 17.8 CCD Chip Type (Full Frame or Interline) 426 17.9 Binning and Frame Rate 426 17.10 Software 427 17.11 Choosing the Right Camera 428 References 429 18 Uncertainty of Measurement 431 Pierre Filion 18.1 Introduction 431 18.2 Purpose 432 18.2.1 Diagnostic Value 432 18.2.2 Internal Quality Control 432 18.2.3 External Quality Control and Accreditation 432 18.3 Factors That Influence Quantitative Measurements 433 18.3.1 Sources of Variation 433 18.3.2 Alteration of the Intrinsic Dimension of the Structure 434 18.3.3 Variation Due to the Analytical Equipment and Method 436 18.3.4 Variation Due to Selection Bias 438 18.3.5 Measurement Using a Digital Camera 439 18.4 How to Calculate the UM 440 18.4.1 Steps Required to Analyse and Calculate the UM 440 18.4.2 Type of Error and Distribution of Measurements 440 18.4.3 Calculating the UM 442 18.4.4 Precision of Measurement and Biological Significance 443 18.4.5 The Electronic Spread Sheet as an Aid to Calculating UM 443 18.4.6 Reporting the UM 444 18.5 Worked Examples 444 18.5.1 Diameter of Fibrils in a Glomerular Deposit 444 18.5.2 Thickness of the Glomerular Basement Membrane 445 18.6 Conclusion 446 References 447 Index 449

Read more less